{
    "testId": 376140559,
    "parentTestId": null,
    "userId": 4331736,
    "sequenceId": 24,
    "qbankId": 2,
    "isSim": 0,
    "testModeId": 2,
    "testModeName": "Tutor",
    "questionModeId": 4,
    "questionModeName": "CUSTOM",
    "testName": "",
    "totalQuestionCorrect": 19,
    "correctToIncorrect": 0,
    "incorrectToCorrect": 0,
    "incorrectToIncorrect": 0,
    "timeInSeconds": 3695,
    "averageTimeSpentInSeconds": 142,
    "otherAverageTimeSpentInSeconds": 75,
    "isStarted": true,
    "isEnded": true,
    "formId": 0,
    "bLockId": 0,
    "subscriptionId": 13863865,
    "lastQuestionVisited": 26,
    "containsMediaQuestion": false,
    "sectionId": 1010,
    "sectionName": "Step 2 Review",
    "difficultyLevelId": null,
    "difficultyLevelName": null,
    "testTypeId": null,
    "testTypeName": null,
    "allottedTime": null,
    "allottedTimeTypeId": null,
    "canResume": null,
    "assignmentId": null,
    "canViewAssignmentResult": null,
    "questionModeIds": "4",
    "testSource": 1,
    "testTypes": "",
    "questionList": [
        {
            "exhibits": null,
            "sequenceId": 1,
            "questionId": 18235,
            "questionIndex": 19702,
            "questionText": "<p>A 38-year-old woman comes to the office due to jaundice.&nbsp; Her eyes have been yellow for the past 8 days, and she has also had pruritus, fever, nausea, and vomiting.&nbsp; The patient has had no unexpected weight loss or bloody stools.&nbsp; Medical history is significant for hypertension; current medications include amlodipine and an oral contraceptive.&nbsp; The patient works in a day care center, where some of the children were recently ill.&nbsp; She drinks alcohol but does not use illicit drugs and is in a monogamous relationship with her husband.&nbsp; Family history is unremarkable.&nbsp; Temperature is 38.7 C (101.7 F), blood pressure is 125/80 mm Hg, and pulse is 80/min.&nbsp; Scleral icterus is present.&nbsp; Oropharyngeal and cardiopulmonary examinations are unremarkable.&nbsp; The neck is supple without lymphadenopathy.&nbsp; The abdomen is nontender and nondistended.&nbsp; The liver edge is smooth and palpable below the right costal margin.&nbsp; Laboratory evaluation reveals the following:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td style=\"vertical-align:middle;\">13.7 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td style=\"vertical-align:middle;\">290,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td style=\"vertical-align:middle;\">12,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Liver function studies</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Albumin</td><td style=\"vertical-align:middle;\">3.9 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Total bilirubin</td><td style=\"vertical-align:middle;\">4.2 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Total protein</td><td style=\"vertical-align:middle;\">6.8 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Alkaline phosphatase</td><td style=\"vertical-align:middle;\">130 U/L</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Aspartate aminotransferase (SGOT)</td><td style=\"vertical-align:middle;\">1534 U/L</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Alanine aminotransferase (SGPT)</td><td style=\"vertical-align:middle;\">1722 U/L</td></tr></tbody></table><p>Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t61546\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Hepatitis A</strong></p></td></tr><tr><td><p align=\"center\"><strong>Transmission<br />&amp; risk factors</strong></p></td><td><ul><li>Fecal-oral transmission</li><li>Poor sanitation/hygiene, travel to endemic areas</li><li>Contaminated food &amp; water</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical<br />presentation</strong></p></td><td><ul><li>Fever, nausea, right upper quadrant pain</li><li>Jaundice, hepatomegaly</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnostic<br />testing</strong></p></td><td><ul><li>Elevated liver transaminases (&gt;1,000&nbsp;U/L)</li><li>Anti&ndash;hepatitis A serology</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Supportive/expectant</li><li>Spontaneous recovery in most patients</li></ul></td></tr></tbody></table></div><p>This patient most likely has <strong>hepatitis A</strong>, which typically begins with <strong>fever</strong>, vomiting, and mild <strong>right upper quadrant (RUQ) pain</strong>.&nbsp; <strong>Jaundice</strong> develops a few days later, often with pruritus, dark urine, and acholic stools.&nbsp; Hepatitis A virus (HAV) undergoes fecal-oral transmission and is commonly acquired from unsanitary food (eg, shellfish) and water supplies; outbreaks may occur in facilities with poor sanitation, such as homeless shelters and <strong>day care centers</strong> (children often do not have jaundice and may go undiagnosed).&nbsp; Unvaccinated persons are at increased risk, as are international travelers and men who have sex with men.</p><p>Hepatomegaly (eg, liver edge palpable below right costal margin) is common in hepatitis A.&nbsp; Liver <strong>transaminases</strong> (eg, aspartate aminotransferase [AST], alanine aminotransferase [ALT]) rise early, often to <strong>&gt;1,000 U/L</strong>.&nbsp; Direct hyperbilirubinemia and mildly elevated alkaline phosphatase are seen soon thereafter and correlate with jaundice.&nbsp; Anti-HAV IgM serology confirms the diagnosis.&nbsp; Treatment is supportive; complete recovery typically occurs within 2-3 months.&nbsp; Fulminant liver failure necessitating liver transplant is rare.</p><p><strong>(Choice A)</strong>&nbsp; Alcoholic hepatitis can cause moderate elevations in liver transaminases, but AST and ALT are rarely &gt;500 U/L; the AST/ALT ratio is usually &gt;2:1.&nbsp; Although this patient uses alcohol, the profound elevations in transaminases are atypical for alcoholic hepatitis.</p><p><strong>(Choice B)</strong>&nbsp; Pyogenic liver abscess can cause fever, hepatomegaly, and elevated liver transaminases, but patients are acutely ill (eg, shaking chills) and have significant leukocytosis.&nbsp; Examination shows marked hepatic tenderness, often with guarding and rocking tenderness (pain caused by gently rocking the abdomen); rebound tenderness may be present.</p><p><strong>(Choice C)</strong>&nbsp; Acute hepatic vein thrombosis (eg, Budd-Chiari syndrome) causes severe RUQ pain, ascites, and hepatosplenomegaly.&nbsp; Absence of ascites and significant RUQ tenderness makes this less likely in this patient.</p><p><strong>(Choice E)</strong>&nbsp; Infectious mononucleosis can cause fever and sometimes jaundice, but splenomegaly is more common than hepatomegaly; patients typically have pharyngitis and cervical lymphadenopathy.</p><p><strong>(Choice F)</strong>&nbsp; Primary biliary cholangitis is characterized by autoimmune destruction of intralobular bile ducts.&nbsp; Typical findings include profound elevations of alkaline phosphatase and bilirubin but near-normal aminotransferase levels.</p><p><strong>(Choice G)</strong>&nbsp; A ruptured hepatic adenoma, which is associated with oral contraceptive use, causes severe RUQ pain and hemorrhagic shock.&nbsp; Although fever, and elevated liver enzymes are common, hypotension, tachycardia, and anemia would also be present.</p><p><strong>Educational objective:</strong><br>Hepatitis A causes fever, vomiting, jaundice, hepatomegaly, and severe elevations in hepatic transaminases (eg, aminotransferase levels &gt;1,000 U/L).&nbsp; Unvaccinated individuals are at increased risk, as are day care workers, homeless shelter residents, international travelers, and men who have sex with men.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 7127,
            "topic": "Hepatitis a",
            "titleId": 7127,
            "title": "Hepatitis a",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "4",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Alcoholic hepatitis",
                    "choiceNumber": 1,
                    "correctTaken": 94,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Bacterial liver abscess",
                    "choiceNumber": 2,
                    "correctTaken": 370,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Budd-Chiari syndrome",
                    "choiceNumber": 3,
                    "correctTaken": 306,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hepatitis A infection",
                    "choiceNumber": 4,
                    "correctTaken": 10923,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Infectious mononucleosis",
                    "choiceNumber": 5,
                    "correctTaken": 198,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Primary biliary cholangitis",
                    "choiceNumber": 6,
                    "correctTaken": 1717,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ruptured hepatic adenoma",
                    "choiceNumber": 7,
                    "correctTaken": 285,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "632,1043,true,-1,1*1455,1508,true,-1,1*1586,1696,true,-1,1*2102,2166,true,-1,1*2499,2546,true,-1,1*2860,3099,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 279,
            "othersAvgTimeSpent": 85,
            "notes": null,
            "peopleTaken": 13893,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 79,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 23,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 2,
            "questionId": 2900,
            "questionIndex": 2900,
            "questionText": "<p>A 35-year-old woman is brought to the emergency department due to 3 days of progressive nausea, anorexia, malaise, abdominal pain, and lethargy.&nbsp; The patient is a chronic carrier of hepatitis B virus and has not received any treatment.&nbsp; She has a history of injection drug use and completed a rehabilitation program 2 years ago, but recently started using drugs again.&nbsp; She drinks alcohol but does not use tobacco.&nbsp; Her temperature is 37.8 C (100.2 F), blood pressure is 106/64 mm Hg, and pulse is 114/min.&nbsp; Mild tender hepatomegaly is present.&nbsp; Laboratory testing shows markedly elevated serum aminotransferase levels and a positive serum hepatitis D antigen.&nbsp; Acute liver failure due to hepatitis D virus superinfection is suspected.&nbsp; Which of the following is required to make a diagnosis of acute liver failure in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><div id=\"div_t80870\"><table class=\"table-default-style table-header-footer-style\" style=\"width:100%\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Acute liver failure</strong></p></td></tr><tr><td><p align=\"center\"><strong>Etiology</strong></p></td><td><ul><li>Viral hepatitis (eg, HSV; CMV; hepatitis A, B, D, E)</li><li>Drug toxicity (eg, acetaminophen overdose, idiosyncratic)</li><li>Ischemia (eg, shock liver, Budd-Chiari syndrome)</li><li>Autoimmune hepatitis</li><li>Wilson disease</li><li>Malignant infiltration</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical presentation</strong></p></td><td><ul><li>Generalized symptoms (eg, fatigue, lethargy, anorexia, nausea)</li><li>Right upper quadrant abdominal pain</li><li>Pruritus &amp; jaundice due to hyperbilirubinemia</li><li>Renal insufficiency</li><li>Thrombocytopenia</li><li>Hypoglycemia</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnostic requirements</strong></p></td><td><ul><li>Severe acute liver injury (ALT &amp; AST often &gt;1,000 U/L)</li><li>Signs of hepatic encephalopathy (eg, confusion, asterixis)</li><li>Synthetic liver dysfunction (INR &ge;1.5)</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>ALT</strong> = alanine aminotransferase; <strong>AST</strong> = aspartate aminotransferase; <strong>CMV</strong> = cytomegalovirus; <strong>HSV</strong> = herpes simplex virus; <strong>INR</strong> = international normalized ratio.</p></td></tr></tbody></table></div></p><p><strong>Acute liver failure (ALF)</strong> is a serious condition characterized by severe acute liver injury in a patient without cirrhosis or underlying liver disease.&nbsp; The diagnosis requires:</p><ul><li>Severe acute liver injury as evidenced by <strong>elevated aminotransferases</strong> (often &gt;1000 U/L)</li><li>Signs of <strong>hepatic encephalopathy (HE)</strong></li><li>Impaired hepatic synthetic function (defined as <strong>INR <u>&gt;</u>1.5</strong>)</li></ul><p>The presence of HE differentiates ALF from acute hepatitis, which has a much better prognosis than ALF.&nbsp; In addition to varying degrees of HE, other common manifestations of ALF include fatigue, lethargy, nausea, vomiting, jaundice, pruritus, and right upper quadrant pain.&nbsp; The most common causes of ALF are drug toxicity (eg, acetaminophen overdose) and <strong>acute viral hepatitis</strong> (eg, hepatitis A virus, hepatitis B virus [HBV]).&nbsp; Other causes include autoimmune hepatitis, ischemia, Wilson disease, and malignant infiltration of the liver.</p><p>Chronic HBV carriers, such as this patient, typically remain asymptomatic without evidence of underlying liver disease (eg, fibrosis).&nbsp; In the presence of HBV, acute <strong>superinfection</strong> with <strong>hepatitis D virus</strong> carries a high risk of ALF development, particularly in intravenous drug users.&nbsp; On further evaluation of this patient, clinical signs of HE and laboratory findings of INR <u>&gt;</u>1.5 would be diagnostic of ALF.</p><p><strong>(Choices A and B)</strong>&nbsp; Decreased urine output (due to intravascular volume depletion and decreased renal perfusion) and elevated portal venous pressure (due to increased resistance to blood flow through the inflamed liver) are both common in ALF.&nbsp; However, neither is specific for ALF or part of the diagnostic criteria.</p><p><strong>(Choice C)</strong>&nbsp; Features of liver cirrhosis include fluid retention, jaundice, caput medusae, palmar erythema, muscle wasting, and gynecomastia.&nbsp; ALF includes some of these features (eg, jaundice, fluid retention), but it is characterized by acute liver injury in a patient without cirrhosis.</p><p><strong>(Choice D)</strong>&nbsp; Severe hyperbilirubinemia is common in ALF and results from a combination of impaired conjugation and impaired excretion of bilirubin.&nbsp; However, it is not a requirement for the diagnosis of ALF.</p><p><strong>Educational objective:</strong><br>Acute liver failure is defined as acute onset of severe liver injury with encephalopathy and impaired synthetic function (defined as INR <u>&gt;</u>1.5) in a patient without cirrhosis or underlying liver disease.&nbsp; Drug toxicity and acute viral hepatitis are the most common causes.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 21090,
            "topic": "Acute liver failure",
            "titleId": 21090,
            "title": "Acute liver failure",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Decreased urine output",
                    "choiceNumber": 1,
                    "correctTaken": 403,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Elevated portal venous pressure",
                    "choiceNumber": 2,
                    "correctTaken": 1545,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Features of liver cirrhosis",
                    "choiceNumber": 3,
                    "correctTaken": 1963,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Severe hyperbilirubinemia",
                    "choiceNumber": 4,
                    "correctTaken": 4802,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Signs of hepatic encephalopathy",
                    "choiceNumber": 5,
                    "correctTaken": 9490,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "198,218,true,-1,1*829,981,true,-1,1*1188,1290,true,-1,1*1862,2009,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "389",
                    "mediaDataId": 0,
                    "title": "Hepatitis B virus (HBV) infection",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "624",
                    "mediaDataId": 0,
                    "title": "Evaluation of abnormal liver function tests (LFTs)",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22447259",
                    "mediaDataId": 0,
                    "title": "Acute liver failure.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22447259",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27043883",
                    "mediaDataId": 0,
                    "title": "Outcomes in adults with acute liver failure between 1998 and 2013: an observational cohort study.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27043883",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27058243",
                    "mediaDataId": 0,
                    "title": "The pathology of acute liver failure.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27058243",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 291,
            "othersAvgTimeSpent": 55,
            "notes": null,
            "peopleTaken": 18203,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 52,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 906,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 3,
            "questionId": 2911,
            "questionIndex": 2911,
            "questionText": "<p>A 45-year-old man comes to the emergency department with poor appetite and nausea for the last 3-4 weeks.&nbsp; He admits to drinking vodka daily.&nbsp; He attempted to quit on several occasions over the last year but relapsed each time.&nbsp; Two years ago, he was admitted for seizures but has had no medical follow-up since.&nbsp; The patient takes no medications and does not use any illicit drugs.&nbsp; He has had no recent sexual encounters.&nbsp; He has no recent unintentional weight loss.&nbsp; His temperature is 37.2 C (99 F), blood pressure is 120/70 mm Hg, and pulse is 102/min.&nbsp; His sclerae appear icteric.&nbsp; The liver is enlarged and mildly tender.&nbsp; The gallbladder is not palpable, and Murphy&#39;s sign is negative.&nbsp; The patient has no abdominal distension, peripheral edema, spider angiomas, gynecomastia, or asterixis.&nbsp; Which of the following laboratory findings are most likely to be present?</p><p>AST = aspartate aminotransferase; ALT = alanine aminotransferase; GGT = gamma-glutamyltransferase.</p>",
            "questionHeader": "",
            "explanationText": "<p><div id=\"div_t80073\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Clinical features of alcoholic hepatitis</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical presentation</strong></p></td><td><ul><li>Jaundice, anorexia, fever</li><li>Right upper quadrant &amp;/or epigastric pain</li><li>Abdominal distension due to ascites</li><li>Proximal muscle weakness from muscle wasting if malnourished</li><li>Possible hepatic encephalopathy</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory &amp; imaging studies</strong></p></td><td><ul><li>Elevated AST &amp; ALT, usually &lt;300 U/L</li><li>AST/ALT ratio &ge;2</li><li>Elevated GGT<strong>,</strong> bilirubin &amp;/or INR</li><li>Leukocytosis, predominantly neutrophils</li><li>Decreased albumin if malnourished</li><li>Abdominal imaging may show fatty liver</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>ALT</strong> = alanine aminotransferase; <strong>AST</strong> = aspartate aminotransferase; <strong>GGT</strong> = gamma-glutamyltransferase<strong>.</strong></p></td></tr></tbody></table></div></p><p>This patient, who has an extensive history of alcohol use, most likely has <strong>alcoholic hepatitis</strong> with jaundice, anorexia, and tender hepatomegaly.&nbsp; There is no evidence of ascites or cirrhosis (eg, spider angiomas, gynecomastia, asterixis).&nbsp; He has no weight loss or systemic symptoms to suggest malignancy, and there are no signs of infection.</p><p>Alcoholic liver disease is generally characterized by modest elevations in aspartate aminotransferase (AST) and alanine aminotransferase (ALT), usually<strong> &lt;300 IU/L</strong> and almost always &lt;500 IU/L.&nbsp; A ratio of <strong>AST to ALT &gt;2</strong> (thought to be due to hepatic deficiency of pyridoxal 5&#39;-phosphate, an ALT enzyme cofactor) is very common in alcoholic liver disease (&gt;90% in one study).&nbsp; However, it is rarely seen with other forms of liver disease, in which ALT is typically higher than AST.&nbsp; This can be used as an important diagnostic marker.&nbsp; There is no correlation between the degree of elevation and liver disease severity.</p><p>Elevations in <strong>gamma-glutamyltransferase (GGT)</strong>, an enzyme present in liver and other cells, and in ferritin, an acute phase reactant, would likely be seen in alcoholic liver disease.&nbsp; Normal values of AST and ALT <strong>(Choice E)</strong> or of GGT and ferritin <strong>(Choice D)</strong> would be less likely.</p><p><strong>(Choices B and C)</strong>&nbsp; If marked elevations (&gt;25 times the upper limit) of AST and ALT are present, toxin-induced (eg, acetaminophen), ischemic, or viral hepatitis should be suspected.</p><p><strong>Educational objective:</strong><br>Alcoholic hepatitis is generally characterized by a ratio of aspartate aminotransferase (AST) to alanine aminotransferase (ALT) &gt;2, elevated gamma-glutamyltransferase, and elevated ferritin.&nbsp; The absolute values of AST and ALT are almost always &lt;500 IU/L in alcoholic liver disease.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 21065,
            "topic": "Alcoholic liver disease",
            "titleId": 21065,
            "title": "Alcoholic liver disease",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "1",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"550\"><tbody><tr align=\"center\"><td width=\"25%\">230</td><td width=\"25%\">111</td><td width=\"25%\">&#8593;</td><td width=\"25%\">&#8593;</td></tr></tbody></table>",
                    "choiceNumber": 1,
                    "correctTaken": 65343,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"550\"><tbody><tr align=\"center\"><td width=\"25%\">2,500</td><td width=\"25%\">1,050</td><td width=\"25%\">&#8593;</td><td width=\"25%\">&#8593;</td></tr></tbody></table>",
                    "choiceNumber": 2,
                    "correctTaken": 19121,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"550\"><tbody><tr align=\"center\"><td width=\"25%\">2,640</td><td width=\"25%\">2,355</td><td width=\"25%\">&#8593;</td><td width=\"25%\">&#8593;</td></tr></tbody></table>",
                    "choiceNumber": 3,
                    "correctTaken": 2693,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"550\"><tbody><tr align=\"center\"><td width=\"25%\">266</td><td width=\"25%\">105</td><td width=\"25%\">Normal</td><td width=\"25%\">Normal</td></tr></tbody></table>",
                    "choiceNumber": 4,
                    "correctTaken": 35304,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"550\"><tbody><tr align=\"center\"><td width=\"25%\">32</td><td width=\"25%\">55</td><td width=\"25%\">&#8593;</td><td width=\"25%\">Normal</td></tr></tbody></table>",
                    "choiceNumber": 5,
                    "correctTaken": 2664,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "198,258,true,-1,1*320,356,true,-1,1*963,1152,true,-1,1*1195,1271,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23101979",
                    "mediaDataId": 0,
                    "title": "Diagnosis and management of alcoholic hepatitis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23101979",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 256,
            "othersAvgTimeSpent": 85,
            "notes": null,
            "peopleTaken": 125125,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 52,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"550\"><tbody><tr align=\"center\"><td width=\"25%\"><strong>AST</strong></td><td width=\"25%\"><strong>ALT</strong></td><td width=\"25%\"><strong>GGT</strong></td><td width=\"25%\"><strong>Ferritin</strong></td></tr></tbody></table>",
            "standards": null,
            "totalTimeSpentReview": 538,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 4,
            "questionId": 14654,
            "questionIndex": 16069,
            "questionText": "<p>A 32-year-old woman is brought to the emergency department an hour after developing acute-onset, right upper quadrant abdominal pain followed by syncope.&nbsp; The patient works at her family farm and felt well prior to the onset of these symptoms.&nbsp; She has no chronic medical conditions.&nbsp; She is sexually active and uses combined estrogen-progestin oral contraceptives. &nbsp;She does not use tobacco, alcohol, or illicit drugs.&nbsp; Temperature is 38.1 C (100.6 F), blood pressure is 80/50 mm Hg, pulse is 120/min, and respirations are 20/min.&nbsp; Oxygen saturation is 95% on room air.&nbsp; The patient appears anxious and pale.&nbsp; Examination shows abdominal distention, diffuse abdominal tenderness, and tender hepatomegaly.&nbsp; Bowel sounds are decreased.&nbsp; Extremities are cold, and capillary refill is delayed.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td style=\"vertical-align:middle;\">9.1 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td style=\"vertical-align:middle;\">180,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td style=\"vertical-align:middle;\">10,200/mm<font size=\"2\"><sup>3</sup></font></td></tr></tbody></table><p>Abdominal ultrasound of the right upper quadrant shows a solid liver mass and free fluid in the abdomen.&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t49834\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Hepatic adenoma</strong></p></td></tr><tr><td><p align=\"center\"><strong>Epidemiology</strong></p></td><td><ul><li>Benign epithelial liver tumor</li><li>Primarily young women on oral contraception</li></ul></td></tr><tr><td><p align=\"center\"><strong>Manifestations</strong></p></td><td><ul><li>Often asymptomatic (incidentally found)</li><li>Episodic right upper quadrant pain</li></ul></td></tr><tr><td><p align=\"center\"><strong>Imaging</strong></p></td><td><ul><li>Solitary, solid lesion in right lobe of liver</li><li>Multiple lesions occasionally occur</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Asymptomatic &amp; &lt;5 cm -&nbsp;stop oral contraception</li><li>Symptomatic or &gt;5 cm -&nbsp;surgical resection</li></ul></td></tr><tr><td><p align=\"center\"><strong>Complications</strong></p></td><td><ul><li>Malignant transformation (~10%)</li><li>Rupture &amp; hemorrhagic&nbsp;shock (~30%)</li></ul></td></tr></tbody></table></div><p>This patient&#39;s hypotension, tachycardia, syncope, poor capillary refill, cold extremities, and anemia indicate likely hemorrhagic shock.&nbsp; Given her sudden-onset, severe right upper quadrant pain, solid liver mass, and free abdominal fluid, the most likely underlying cause is a <strong>ruptured hepatic adenoma</strong>.</p><p>Hepatic adenomas generally arise in <strong>young women</strong> who have been on prolonged estrogen-based <strong>oral contraception</strong>.&nbsp; Although considered benign and often discovered incidentally on imaging for other conditions, hepatic adenoma can cause life-threatening complications such as malignant transformation and <strong>rupture</strong>.&nbsp; Rupture should be suspected in those with sudden-onset, <strong>severe right upper quadrant pain</strong> who have signs of <strong>hemorrhagic shock</strong>; low-grade fever and mild leukocytosis also sometimes occur due to peritoneal irritation from blood in the abdominal cavity.&nbsp; Ultrasound generally reveals a single, solid liver lesion (usually in the right hepatic lobe) and free fluid (blood) in the abdomen.&nbsp; Urgent circulatory support and surgical intervention are required to prevent death.</p><p><strong>(Choice A)</strong>&nbsp; Focal nodular hyperplasia is a benign liver lesion seen most often in young women.&nbsp; It is not linked to oral contraception use and is usually asymptomatic; complications such as rupture or malignant transformation do not generally occur.</p><p><strong>(Choice B)</strong>&nbsp; Hepatic abscess is most common in the setting of bowel perforation or biliary infection.&nbsp; Although patients often have fever and progressive right upper quadrant pain, the presence of sudden right upper quadrant pain and hemorrhagic shock (eg, syncope, poor perfusion/capillary refill) would be atypical.&nbsp; In addition, ultrasound usually shows a lesion with internal debris or septation (not a solid mass).</p><p><strong>(Choice D)</strong>&nbsp; Hepatic hemangioma is the most common benign liver lesion.&nbsp; It is generally asymptomatic, but larger lesions can sometimes cause right upper quadrant pain.&nbsp; Spontaneous rupture of this vascular lesion is very rare; therefore, a solid liver lesion with surrounding free fluid is unlikely.</p><p><strong>(Choice E)</strong>&nbsp; Hepatocellular carcinoma usually occurs in older individuals with long-standing alcohol abuse or chronic viral hepatitis.&nbsp; Most cases present with progressive, subacute right upper quadrant abdominal pain or decompensated cirrhosis.&nbsp; This young patient with no history of chronic hepatitis or alcohol abuse is unlikely to have hepatocellular carcinoma.</p><p><strong>(Choice F)</strong>&nbsp; Hydatid cysts can occasionally rupture into the abdomen, leading to sudden-onset, right upper quadrant pain, fever, and leukocytosis.&nbsp; However, ultrasound would reveal a smooth, round cyst in the liver, not a solid mass.</p><p><strong>Educational objective:</strong><br>Young women on prolonged oral contraception are at greatest risk for hepatic adenoma.&nbsp; Although most lesions are benign and asymptomatic, life-threatening complications such as malignant transformation or rupture can occur.&nbsp; Rupture should be suspected in the setting of sudden-onset, severe right upper quadrant pain and signs of hemorrhagic shock.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 7120,
            "topic": "Hepatic adenomas",
            "titleId": 7120,
            "title": "Hepatic adenomas",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Focal nodular hyperplasia",
                    "choiceNumber": 1,
                    "correctTaken": 569,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hepatic abscess",
                    "choiceNumber": 2,
                    "correctTaken": 2297,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hepatic adenoma",
                    "choiceNumber": 3,
                    "correctTaken": 7975,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hepatic hemangioma",
                    "choiceNumber": 4,
                    "correctTaken": 3465,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hepatocellular carcinoma",
                    "choiceNumber": 5,
                    "correctTaken": 338,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hydatid cyst",
                    "choiceNumber": 6,
                    "correctTaken": 2984,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1000,1103,true,-1,1*1489,1574,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 77,
            "othersAvgTimeSpent": 65,
            "notes": null,
            "peopleTaken": 17628,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 45,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 663,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 5,
            "questionId": 14653,
            "questionIndex": 16068,
            "questionText": "<p>A 34-year-old woman comes to the office due to sudden onset epigastric pain radiating to the back, nausea, and vomiting.&nbsp; Her medical history is significant for major depression, generalized anxiety, and irregular menses.&nbsp; She takes sertraline and an oral contraceptive.&nbsp; The patient describes occasional heavy alcohol use and drinks hard liquor daily.&nbsp; She does not use tobacco or illicit drugs.&nbsp; Temperature is 37 C (98.6 F), blood pressure is 120/80 mm Hg, pulse is 98/min, and respirations are 18/min.&nbsp; BMI is 24 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; No jaundice is present.&nbsp; Examination shows epigastric tenderness.&nbsp; Serum lipase levels are markedly elevated.&nbsp; Abdominal ultrasonogram reveals an enlarged pancreas, no gallstones, and normal gallbladder; a mass is also noted in the right lobe of the liver.&nbsp; Subsequent abdominal CT scan reveals a well-circumscribed, 5-cm mass with a central scar that appears hypodense on noncontrast imaging.&nbsp; Imaging with contrast indicates the lesion is hyperdense.&nbsp; The rest of the liver appears to be normal, and there is no intra- or extrahepatic duct dilatation.&nbsp; Which of the following is the most likely diagnosis for the liver lesion?</p>",
            "questionHeader": "",
            "explanationText": "<p><div id=\"div_t81416\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Solid liver masses</strong></p></td></tr><tr><td><p align=\"center\"><strong>Focal nodular hyperplasia</strong></p></td><td><ul><li>Associated with anomalous arteries</li><li>Arterial flow &amp; central scar on imaging</li></ul></td></tr><tr><td><p align=\"center\"><strong>Hepatic adenoma</strong></p></td><td><ul><li>Women on long-term oral contraceptives</li><li>Possible hemorrhage or malignant transformation</li></ul></td></tr><tr><td><p align=\"center\"><strong>Regenerative nodules</strong></p></td><td><ul><li>Acute or chronic liver injury (eg, cirrhosis)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Hepatocellular carcinoma</strong></p></td><td><ul><li>Systemic symptoms</li><li>Chronic hepatitis or cirrhosis</li><li>Elevated &#593; fetoprotein</li></ul></td></tr><tr><td><p align=\"center\"><strong>Liver metastasis</strong></p></td><td><ul><li>Single/multiple lesions</li><li>Known extrahepatic malignancy</li></ul></td></tr></tbody></table></div></p><p>This patient&#39;s heavy alcohol use, acute epigastric pain radiating to the back, elevated lipase, and enlarged pancreas indicate acute pancreatitis.&nbsp; The presence of a well-circumscribed liver lesion with a central scar likely represents an incidental finding of <strong>focal nodular hyperplasia (FNH)</strong>, a benign regenerative liver nodule common in <strong>women</strong> age 20-50.</p><p>Most cases of FNH are asymptomatic and are discovered during abdominal imaging for other conditions.&nbsp; Lesions tend to be well-circumscribed, solitary, and &lt;5 cm in size; they characteristically have a <strong>central</strong>, <strong>stellate scar</strong>, which surrounds a large congenital arterial anomaly that sends arterial branches to the periphery.&nbsp; Imaging with triphasic, helical CT scan (which evaluates the mass during different phases of vascular contrast) generally reveals a <strong>hyperdense lesion</strong> (ie, filled with contrast during hepatic arterial phase) and a central scar.</p><p>Because FNH does not generally grow over time, undergo malignant transformation, or rupture, <strong>treatment is rarely required</strong>.&nbsp; Oral contraception is not believed to worsen FNH; therefore, contraception usually can be continued (in contrast to hepatic adenoma).</p><p><strong>(Choice B)</strong>&nbsp; Hepatic hemangioma, the most common benign liver tumor, is often found incidentally during imaging for other conditions.&nbsp; However, triphasic CT scan will reveal centripetal enhancement (ie, enhancement moving from periphery to center) and no central scar.</p><p><strong>(Choice C)</strong>&nbsp; Hepatic adenomas are benign liver tumors that often arise in the right lobe of the liver in women on oral contraception (possibly due to effects of estrogen on hepatocyte, although studies have been inconclusive).&nbsp; However, centripetal enhancement is usually seen on triphasic CT scan, and no central scar would be present.</p><p><strong>(Choice D)</strong>&nbsp; Hepatocellular carcinoma is a malignant liver tumor that usually arises in the setting of chronic liver disease (eg, cirrhosis, viral hepatitis).&nbsp; Patients are often asymptomatic but may develop weight loss or early satiety.&nbsp; Although hepatocellular carcinoma enhances with contrast, a central scar is atypical.</p><p><strong>(Choice E)</strong>&nbsp; Hepatic cirrhosis is common in individuals who consume excessive amounts of alcohol.&nbsp; Nonspecific symptoms (eg, fatigue, weight loss) often occur, and patients may develop ascites, hepatic encephalopathy, or jaundice.&nbsp; Cirrhosis is marked by hepatic fibrosis, distortion of normal hepatic architecture, and regenerative nodules, so imaging generally reveals a shrunken, irregular liver with innumerable small nodules.</p><p><strong>(Choice F)</strong>&nbsp; The liver is a common site of metastases from a wide range of tumors (eg, pancreatic, colorectal, breast).&nbsp; Although solitary lesions can occur, multiple lesions are most common.&nbsp; In addition, a central scar would be atypical.</p><p><strong>Educational objective:</strong><br>Focal nodular hyperplasia is a benign liver lesion due to an aberrant congenital artery.&nbsp; It is usually found incidentally in young women and is marked by the presence of a stellate central scar and radiating fibrous bands.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 1529,
            "topic": "Focal nodular hyperplasia",
            "titleId": 1529,
            "title": "Focal nodular hyperplasia",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Focal nodular hyperplasia",
                    "choiceNumber": 1,
                    "correctTaken": 8631,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hemangioma",
                    "choiceNumber": 2,
                    "correctTaken": 2400,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hepatic adenoma",
                    "choiceNumber": 3,
                    "correctTaken": 7323,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hepatocellular carcinoma",
                    "choiceNumber": 4,
                    "correctTaken": 1367,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Liver cirrhosis",
                    "choiceNumber": 5,
                    "correctTaken": 246,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Solitary hepatic metastasis",
                    "choiceNumber": 6,
                    "correctTaken": 775,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "395,417,true,-1,1*1046,1397,true,-1,1*1798,1923,true,-1,1*2160,2258,true,-1,1*3099,3132,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 56,
            "othersAvgTimeSpent": 65,
            "notes": null,
            "peopleTaken": 20742,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 42,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 2467,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 6,
            "questionId": 2901,
            "questionIndex": 2901,
            "questionText": "<p>A 52-year-old man is admitted to the hospital due to fatigue and abdominal discomfort.&nbsp; The patient has had no nausea, vomiting, constipation, or diarrhea.&nbsp; Medical history is significant for cirrhosis due to chronic alcohol use.&nbsp; Medications include spironolactone and furosemide.&nbsp; He had an inguinal hernia repaired 20 years ago.&nbsp; Temperature is 37.9 C (100.2 F), blood pressure is 102/68 mm Hg, and pulse is 106/min.&nbsp; The patient is awake, alert, and oriented to time, place, and person but is unable to successfully perform a timed connect-the-numbers test.&nbsp; Auscultation of the heart and lungs is normal.&nbsp; Abdominal examination shows moderate ascites with diffuse tenderness to palpation.&nbsp; There is no rigidity or rebound tenderness.&nbsp; Bowel sounds are decreased.&nbsp; Rectal examination is normal with guaiac-negative brown stool.&nbsp; Abdominal x-ray reveals dilated loops of small and large bowel with air in the colon and rectum.&nbsp; Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T34844\" style=\"overflow-x:auto;\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Spontaneous bacterial peritonitis</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical presentation</strong></p></td><td><ul><li>Temperature &#8805;37.8 C (100 F)</li><li>Abdominal pain/tenderness</li><li>Altered mental status (abnormal connect-the-numbers test)</li><li>Hypotension, hypothermia, paralytic ileus with severe infection</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis from ascitic fluid</strong></p></td><td><ul><li>PMNs &#8805;250/mm<sup>3</sup></li><li>Positive culture, often gram-negative organisms (eg, <em>Escherichia coli</em>, <em>Klebsiella</em>)</li><li>Protein &lt;1 g/dL</li><li>SAAG &#8805;1.1 g/dL</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Empiric antibiotics - third-generation cephalosporins (eg, cefotaxime)</li><li>Fluoroquinolones for SBP prophylaxis</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>PMN</strong> = polymorphonuclear leukocytes; <strong>SAAG</strong> = serum-ascites albumin gradient; <strong>SBP</strong> = spontaneous bacterial peritonitis.</p></td></tr></tbody></table></div><p>This patient with <strong>ascites</strong> (due to cirrhosis) has abdominal tenderness and a subtle alteration in mental status (ie, inability to complete a psychometric test).&nbsp; Along with low-grade fever, these findings raise concern for <strong>spontaneous bacterial peritonitis</strong> (SBP), which can present on a spectrum of severity from asymptomatic to septic shock.</p><p>In contrast to peritonitis caused by bowel perforation, SBP is likely caused by enteric bacteria translocation (eg, <em>Escherichia coli</em>) or hematogenous spread (eg, pneumococcal pneumonia).&nbsp; It often presents with only mild abdominal tenderness <strong>without rigidity or rebound tenderness</strong>, possibly from ascites serving as a cushion between the parietal and visceral peritoneal surfaces.&nbsp; SBP, particularly if severe, can be accompanied by paralytic ileus, as in this patient with decreased bowel sounds and x-ray findings of <a href=\"24766\">dilated loops of bowel</a>.</p><p>Because SBP can have a subtle presentation, there should be a low threshold for obtaining a <strong>diagnostic paracentesis</strong> with fluid analysis in patients with ascites.&nbsp; SBP is diagnosed based on an ascitic fluid neutrophil count of <strong>&#8805;250/mm<font size=\"2\"><sup>3</sup></font></strong>.&nbsp; Treatment requires the administration of empiric intravenous antibiotics with reliable coverage against potentially causative organisms; <strong>third-generation cephalosporins</strong> (eg, ceftriaxone) are typically used.</p><p><strong>(Choice A)</strong>&nbsp; Acute pancreatitis, commonly caused by heavy alcohol use, can also result in abdominal pain and fever (in severe cases).&nbsp; However, the pain is typically epigastric and radiates to the back; nausea and vomiting are usually present.</p><p><strong>(Choice B)</strong>&nbsp; Alcoholic hepatitis can also cause fever (due to cytokine release from injured hepatocytes), abdominal pain, ascites, and mental status changes.&nbsp; However, tenderness is typically located in the right upper quadrant rather than diffusely throughout the abdomen.&nbsp; Furthermore, most patients have obvious jaundice due to significantly elevated bilirubin levels.</p><p><strong>(Choice C)</strong>&nbsp; Peptic ulcer perforation leads to the leakage of gastric contents into the peritoneal cavity, which results in severe abdominal pain with rigidity and rebound tenderness; these findings are absent in this patient.&nbsp; In addition, abdominal x-ray would likely reveal <a href=\"4313\">free air under the diaphragm</a>.</p><p><strong>(Choice D)</strong>&nbsp; Small bowel obstruction would demonstrate only <a href=\"64541\">dilated loops of small bowel</a> (without dilated loops of large bowel) on x-ray; also, nausea and vomiting would be expected, and bowel sounds are initially high-pitched.</p><p><strong>Educational objective:</strong><br>Abdominal tenderness and any alteration in mental status should raise suspicion for spontaneous bacterial peritonitis.&nbsp; Rigidity or rebound tenderness may be absent due to ascites serving as a cushion between the parietal and visceral peritoneal surfaces.&nbsp; Empiric intravenous antibiotics should be administered if diagnostic paracentesis shows &#8805;250/mm<font size=\"2\"><sup>3</sup></font> neutrophils.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 19410,
            "topic": "Spontaneous bacterial peritonitis",
            "titleId": 19410,
            "title": "Spontaneous bacterial peritonitis",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acute pancreatitis",
                    "choiceNumber": 1,
                    "correctTaken": 266,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Alcoholic hepatitis",
                    "choiceNumber": 2,
                    "correctTaken": 1069,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Peptic ulcer perforation",
                    "choiceNumber": 3,
                    "correctTaken": 522,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Small bowel obstruction",
                    "choiceNumber": 4,
                    "correctTaken": 4783,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Spontaneous bacterial peritonitis",
                    "choiceNumber": 5,
                    "correctTaken": 9657,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "162,197,true,-1,1*198,261,true,-1,1*487,499,true,-1,1*500,536,true,-1,1*1376,1512,true,-1,1*1947,1961,true,-1,1*2236,2329,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "355",
                    "mediaDataId": 0,
                    "title": "Complications of cirrhosis",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30666172",
                    "mediaDataId": 0,
                    "title": "Spontaneous bacterial peritonitis in patients with cirrhosis: incidence, outcomes, and treatment strategies.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30666172",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 148,
            "othersAvgTimeSpent": 78,
            "notes": null,
            "peopleTaken": 16297,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 59,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1581,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 7,
            "questionId": 2926,
            "questionIndex": 2926,
            "questionText": "<p>A 34-year-old woman has laboratory tests performed prior to entering nursing school.&nbsp; The patient has no significant medical history and takes no medications.&nbsp; She is currently in a monogamous relationship and does not use recreational drugs.&nbsp; The patient believes she is up to date with all vaccinations.&nbsp; She brings the following report with her to the clinic.</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">HBsAg</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"vertical-align:middle;\">Anti-HBs</td><td style=\"vertical-align:middle;\">positive</td></tr><tr><td style=\"vertical-align:middle;\">Total anti-HBc</td><td style=\"vertical-align:middle;\">positive</td></tr><tr><td style=\"vertical-align:middle;\">HBeAg</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"vertical-align:middle;\">Anti-HBe</td><td style=\"vertical-align:middle;\">negative</td></tr></tbody></table><p>Which of the following is the appropriate interpretation of these serological test results?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T100390\" style=\"overflow-x:auto;\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"></td><td><p align=\"center\"><strong>HBsAg</strong></p></td><td><p align=\"center\"><strong>HBeAg</strong></p></td><td><p align=\"center\"><strong>IgM</strong></p><p align=\"center\"><strong>anti-HBc</strong></p></td><td><p align=\"center\"><strong>IgG</strong></p><p align=\"center\"><strong>anti-HBc</strong></p></td><td><p align=\"center\"><strong>Anti-HBs</strong></p></td><td><p align=\"center\"><strong>Anti-HBe</strong></p></td><td><p align=\"center\"><strong>HBV DNA</strong></p></td></tr><tr><td rowspan=\"3\"><p align=\"center\"><strong>Acute HBV</strong></p></td><td><p align=\"center\"><em>Early phase</em></p></td><td><p align=\"center\">+</p></td><td><p align=\"center\">+</p></td><td><p align=\"center\">+</p></td><td></td><td></td><td></td><td><p align=\"center\">+++</p></td></tr><tr><td><p align=\"center\"><em>Window period</em></p></td><td></td><td></td><td><p align=\"center\">+</p></td><td></td><td></td><td></td><td><p align=\"center\">+</p></td></tr><tr><td><p align=\"center\"><em>Recovery</em></p></td><td></td><td></td><td></td><td><p align=\"center\">+</p></td><td><p align=\"center\">+</p></td><td><p align=\"center\">+</p></td><td><p align=\"center\">Likely +</p></td></tr><tr><td colspan=\"2\"><p align=\"center\"><strong>Chronic active HBV infection</strong></p></td><td><p align=\"center\">+</p></td><td><p align=\"center\">+/&#8722;</p></td><td></td><td><p align=\"center\">+</p></td><td></td><td><p align=\"center\">+/&#8722;</p></td><td><p align=\"center\">++</p></td></tr><tr><td colspan=\"2\"><p align=\"center\"><strong>Inactive HBV carrier state</strong></p></td><td><p align=\"center\">+</p></td><td></td><td></td><td></td><td></td><td><p align=\"center\">+</p></td><td><p align=\"center\">Normal/ mildly +</p></td></tr><tr><td colspan=\"2\"><p align=\"center\"><strong>Vaccinated for HBV</strong></p></td><td></td><td></td><td></td><td></td><td><p align=\"center\">+</p></td><td></td><td></td></tr><tr><td colspan=\"2\"><p align=\"center\"><strong>Immune due to natural HBV infection</strong></p></td><td></td><td></td><td></td><td><p align=\"center\">+</p></td><td><p align=\"center\">+</p></td><td></td><td></td></tr><tr><td colspan=\"9\"><p><strong>HBV</strong>= hepatitis B virus.</p></td></tr></tbody></table></div><p>This patient&#39;s serologic test results are consistent with <strong>resolved hepatitis B virus (HBV) infection</strong>.&nbsp; Individuals who are immune to HBV due to natural infection have the following serological features:</p><ul><li><p><strong>positive anti-HBs</strong>, indicating immunity by the presence of antibodies against viral surface antigen.&nbsp; This result is also found in individuals who have mounted a successful response to the HBV vaccine.</p></li><li><p><strong>negative HBsAg</strong>, indicating cleared infection.</p></li><li><p><strong>positive anti-HBc</strong> (ie, antibodies against HBV core antigen), which is found only in response to viral infection and not vaccination.&nbsp; In early infection, IgM anti-HBc may be the only diagnostic marker for acute infection during the window period of infection (when HBsAg has disappeared but anti-HBs has not yet appeared).&nbsp; In contrast, during recovery, resolved illness, or progression to chronic infection, total anti-HBc consists primarily of IgG.</p></li><li><p><strong>negative HBeAg</strong>, indicating low infectivity and viral load.&nbsp; HBeAg and anti-HBeAg antibody are positive only in a subset of patients and typically correlate with active viral replication (eg, early infection, chronic infection with viral replication).&nbsp; Anti-HBeAg is typically evident in the recovery phase of acute infection; levels can wane over time, sometimes becoming undetectable in patients with long-resolved infection or persistent chronic infection.</p></li></ul><p><strong>(Choices A and B)</strong>&nbsp; <a href=\"1161\">Chronic HBV infection</a>, whether active or inactive (eg, carrier state), is characterized by positive HBsAg and absence of anti-HBs, neither of which are seen in this patient.&nbsp; Chronic active infection is evidenced by viral replication or infectivity (eg, positive HBeAg, persistently elevated HBV DNA) whereas inactive infection is characterized by low viral load and positive anti-HBe.</p><p><strong>(Choice D)</strong>&nbsp; Patients with vaccine-induced immunity against HBV have positive anti-HBs and negative HBsAg and anti-HBc.&nbsp; The vaccine contains only the surface component, therefore antibodies against the core component are not expected.</p><p><strong>(Choice E)</strong>&nbsp; In the window period, HBsAg disappears before the level of anti-HBs becomes detectable on laboratory testing; therefore, anti-HBc is the only detectable antibody.&nbsp; This patient has positive anti-HBs, which is not seen in the window period.</p><p><strong>Educational objective:</strong><br>Individuals with resolved hepatitis B virus (HBV) infection are positive for anti-HBs and anti-HBc (IgG) but negative for HBsAg.&nbsp; In contrast, individuals who are immunized with the HBV vaccine have only detectable anti-HBs (no anti-HBc).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 7134,
            "topic": "Hepatitis b",
            "titleId": 7134,
            "title": "Hepatitis b",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Chronic active hepatitis B virus infection",
                    "choiceNumber": 1,
                    "correctTaken": 360,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Inactive hepatitis B virus carrier state",
                    "choiceNumber": 2,
                    "correctTaken": 879,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Resolved hepatitis B virus infection",
                    "choiceNumber": 3,
                    "correctTaken": 10875,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vaccination against hepatitis B virus infection",
                    "choiceNumber": 4,
                    "correctTaken": 1867,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Window phase of hepatitis B virus infection",
                    "choiceNumber": 5,
                    "correctTaken": 1963,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "959,1277,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "389",
                    "mediaDataId": 0,
                    "title": "Hepatitis B virus (HBV) infection",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30811163",
                    "mediaDataId": 0,
                    "title": "Hepatitis B: screening, prevention, diagnosis, and treatment.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30811163",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 74,
            "othersAvgTimeSpent": 40,
            "notes": null,
            "peopleTaken": 15944,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 68,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 978,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 8,
            "questionId": 4747,
            "questionIndex": 4747,
            "questionText": "<p>A 44-year-old man comes to the emergency department for exertional dyspnea, abdominal distention, and abdominal discomfort.&nbsp; He has a history of alcohol abuse, peptic ulcer disease, and acute pancreatitis.&nbsp; Physical examination shows a distended abdomen with shifting dullness and 1+ ankle edema.&nbsp; A diagnostic paracentesis is performed and shows the following:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td width=\"70%\">Albumin</td><td>2.5 g/dL</td></tr><tr><td>Neutrophils</td><td>200/&micro;L</td></tr><tr><td>Lactate dehydrogenase</td><td>40 units/L</td></tr><tr><td>Glucose</td><td>80 mg/dL</td></tr><tr><td>Amylase</td><td>40 units/L</td></tr></tbody></table><p>Blood studies show the following:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td width=\"70%\">Albumin</td><td>3.8 g/dL</td></tr><tr><td>Potassium</td><td>3.2 mEq/L</td></tr><tr><td>Sodium</td><td>130 mEq/L</td></tr><tr><td>Glucose</td><td>120 mg/dL</td></tr><tr><td>Aspartate aminotransferase (AST)</td><td>50 units/L</td></tr><tr><td>Alanine aminotransferase (ALT)</td><td>40 units/L</td></tr><tr><td>Lactate dehydrogenase</td><td>100 units/L</td></tr><tr><td>Amylase</td><td>80 units/L</td></tr><tr><td>Creatinine</td><td>1.2 mg/dL</td></tr></tbody></table><p>Which of the following is the most likely cause of this patient&#39;s ascites?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t34595\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Ascitic&nbsp;fluid characteristics</strong></p></td></tr><tr><td><p align=\"center\"><strong>Gross appearance</strong></p></td><td><ul><li>Typically straw-colored &amp; clear</li><li>Bloody: suggests trauma or malignancy</li><li>Cloudy: suggests infection</li><li>Milky: suggests lymphatic disruption (chylous)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Serum-to-ascites<br />albumin gradient (SAAG)</strong></p></td><td><ul><li>&ge;1.1 g/dL indicates portal HTN<ul style=\"list-style-type:circle;\"><li>Causes include cirrhosis, heart failure</li></ul></li><li>&lt;1.1 g/dL indicates no portal HTN<ul style=\"list-style-type:circle;\"><li>Causes include malignancy, TB, nephrotic syndrome</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Total protein</strong></p></td><td><ul><li>&lt;2.5 g/dL is consistent with cirrhosis or nephrotic syndrome</li></ul></td></tr><tr><td><p align=\"center\"><strong>Cell count</strong></p></td><td><ul><li>&ge;250 neutrophils/mm<sup>3</sup> is diagnostic of SBP</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>HTN</strong>&nbsp;=&nbsp;hypertension; <strong>SBP</strong>&nbsp;=&nbsp;spontaneous bacterial peritonitis; <strong>TB</strong>&nbsp;=&nbsp;tuberculosis.</p></td></tr></tbody></table></div><p>Ascites can be due to portal hypertensive (eg, cardiac ascites, cirrhosis) or non-portal hypertensive (eg, malignancy, pancreatitis, nephrotic syndrome, tuberculosis) causes.&nbsp; Assessment of color, neutrophil count, total protein, and the <strong>serum-to-ascites albumin gradient (SAAG)</strong> in <strong>ascitic fluid analysis</strong> can help to diagnose the etiology.</p><p><strong>SAAG</strong> is calculated by subtracting the peritoneal fluid albumin concentration from the serum albumin concentration and is useful to differentiate between portal and non-portal hypertensive etiologies.&nbsp; A SAAG <u>&gt;</u>1.1 g/dL indicates portal hypertension while a SAAG &lt;1.1 g/dL suggests other causes.&nbsp; This patient&#39;s SAAG of 1.3 g/dL (3.8 &ndash; 2.5 g/dL) is consistent with portal hypertension (eg, cirrhosis) with increased hydrostatic pressure within hepatic capillary beds.</p><p><strong>(Choice A)</strong>&nbsp; Decreased liver synthetic function leads to decreased serum albumin concentration and increased prothrombin time (INR).&nbsp; Hypoalbuminemia may contribute to edema in end-stage liver disease, but this patient&#39;s normal serum albumin makes this less likely.</p><p><strong>(Choice C)</strong>&nbsp; Increased capillary permeability (eg, malignant ascites) typically leads to non-portal hypertensive ascites with a SAAG &lt;1.1 g/dL.</p><p><strong>(Choice D)</strong>&nbsp; Increased glomerular filtration pressure usually increases the glomerular filtration rate and decreases serum creatinine.&nbsp; However, it typically does not cause ascites.</p><p><strong>(Choice E)</strong>&nbsp; Although primary hyperaldosteronism causes sodium and water retention, it typically does not cause significant ascites or edema due to spontaneous diuresis (aldosterone escape phenomena).</p><p><strong>Educational objective:</strong><br>In evaluating ascites, a serum-to-ascites albumin gradient (SAAG) <u>&gt;</u>1.1 g/dL indicates portal hypertensive etiologies (eg, cardiac ascites, cirrhosis) while a SAAG &lt;1.1 suggests non-portal hypertensive etiologies (eg, malignancy, pancreatitis, nephrotic syndrome, tuberculosis).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 2802,
            "topic": "Ascites",
            "titleId": 2802,
            "title": "Ascites",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Decreased liver synthetic activity",
                    "choiceNumber": 1,
                    "correctTaken": 21059,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increased capillary hydrostatic pressure",
                    "choiceNumber": 2,
                    "correctTaken": 67741,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increased capillary permeability",
                    "choiceNumber": 3,
                    "correctTaken": 31720,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increased glomerular filtration pressure",
                    "choiceNumber": 4,
                    "correctTaken": 1485,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Primary hyperaldosteronism",
                    "choiceNumber": 5,
                    "correctTaken": 1365,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1259,1430,true,-1,1*1706,1838,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "19577115",
                    "mediaDataId": 0,
                    "title": "Ascites: diagnosis and management.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/19577115",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24292307",
                    "mediaDataId": 0,
                    "title": "Serum-ascites albumin gradient in differential diagnosis of ascites.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24292307",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 117,
            "othersAvgTimeSpent": 89,
            "notes": null,
            "peopleTaken": 123370,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 55,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 796,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 9,
            "questionId": 2953,
            "questionIndex": 2953,
            "questionText": "<p>A 60-year-old man is brought to the emergency department due to progressive lethargy.&nbsp; The patient has a history of alcoholic cirrhosis and was recently seen in his primary care provider&#39;s office for increasing abdominal distension and leg swelling.&nbsp; His wife says that the swelling improved slightly after furosemide and spironolactone were started, but for the last 2 days he has been confused and irritable.&nbsp; The patient has slept most of the time and has not eaten.&nbsp; Temperature is 36.7 C (98 F), blood pressure is 96/50 mm Hg, and pulse is 96/min.&nbsp; On examination, the patient appears lethargic but is arousable.&nbsp; He is not very cooperative and at times is agitated.&nbsp; Mucous membranes are dry.&nbsp; His outstretched hands exhibit a flapping tremor.&nbsp; The abdomen is nontender and distended, and shifting dullness is present.&nbsp; Bilateral lower extremity pitting edema is present.&nbsp; Stool occult blood is negative.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td>Leukocytes</td><td>8,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>Platelets</td><td>120,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" height=\"15\"></td></tr><tr><td colspan=\"2\">Serum chemistry</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Sodium</td><td>134 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Potassium</td><td>3.0 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Bicarbonate</td><td>30 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Blood urea nitrogen</td><td>28 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Creatinine</td><td>1.1 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Glucose</td><td>80 mg/dL</td></tr></tbody></table><p>Which of the following is the best initial treatment for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t34440\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Hepatic encephalopathy</strong></p></td></tr><tr><td><p align=\"center\"><strong>Precipitating factors</strong></p></td><td><ul><li>Drugs (eg, sedatives, narcotics)</li><li>Hypovolemia (eg, diarrhea)</li><li>Electrolyte changes (eg, hypokalemia)</li><li>&uarr; Nitrogen load (eg, GI bleeding)</li><li>Infection (eg, pneumonia, UTI, SBP)</li><li>Portosystemic shunting (eg, TIPS)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical presentation</strong></p></td><td><ul><li>Sleep pattern changes</li><li>Altered mental status</li><li>Ataxia</li><li>Asterixis</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Correct precipitating causes (eg, fluids, antibiotics)</li><li>&darr; Blood ammonia concentration (eg, lactulose, rifaximin)</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>GI</strong>&nbsp;=&nbsp;gastrointestinal; <strong>SBP</strong>&nbsp;=&nbsp;spontaneous bacterial peritonitis; <strong>TIPS</strong>&nbsp;=&nbsp;transjugular intrahepatic portosystemic shunt; <strong>UTI</strong>&nbsp;=&nbsp;urinary tract infection.</p></td></tr></tbody></table></div><p>This patient with <strong>cirrhosis</strong> has lethargy, confusion, and asterixis (flapping tremor with outstretched hands) suggestive of <strong>hepatic encephalopathy (HE)</strong>.&nbsp; HE refers to impaired central nervous system (CNS) function in patients with cirrhosis and is due in part to the neurotoxicity from ammonia (NH<font size=\"2\"><sub>3</sub></font>) in the setting of impaired liver function.</p><p>In this patient, HE was likely triggered by the recent initiation of <strong>diuretic</strong> therapy.&nbsp; This, along with poor oral intake, led to <strong>low intravascular volume</strong> (hypotension, dry mucous membranes) with:</p><ul><li><strong>Hypokalemia</strong>, which can exacerbate HE as the resultant intracellular acidosis (excreted intracellular potassium replaced by hydrogen ions to maintain electroneutrality) causes increased NH<font size=\"2\"><sub>3</sub></font> production (glutamine conversion) in renal tubular cells</li><li><strong>Metabolic alkalosis</strong> (elevated bicarbonate), which can also exacerbate HE as it promotes conversion of ammonium (NH<font size=\"2\"><sub>4</sub></font><font size=\"2\"><sup>+</sup></font>), which cannot enter the CNS, to NH<font size=\"2\"><sub>3</sub></font>, which can enter the CNS</li></ul><p>As a result, patients with HE and hypokalemia require prompt <strong>potassium repletion</strong> in addition to intravascular <strong>volume repletion</strong>.&nbsp; Disaccharides (eg, <strong>lactulose</strong>, lactitol) are also administered to lower NH<font size=\"2\"><sub>3</sub></font> levels.</p><p><strong>(Choice A)</strong>&nbsp; Patients with cirrhosis tend to be malnourished; therefore, dietary protein restriction is generally not recommended.&nbsp; Protein-free diets can cause a negative nitrogen balance and increase mortality.&nbsp; Protein restriction is generally limited to patients who have required <a href=\"5805\">transjugular intrahepatic portosystemic shunting (TIPS)</a>.</p><p><strong>(Choice B)</strong>&nbsp; Lorazepam can be used to treat alcohol withdrawal; however, this patient does not have typical manifestations of withdrawal (eg, tachycardia, hypertension, tremor).</p><p><strong>(Choice C)</strong>&nbsp; Neomycin is a nonabsorbable antibiotic used to treat HE in patients unresponsive to lactulose and those unable to tolerate rifaximin.</p><p><strong>(Choice E)</strong>&nbsp; TIPS is performed when a patient has ascites that does not respond to medical therapy (eg, diuretics) or has ongoing active or recurrent variceal bleeding even after appropriate treatment with upper endoscopy.&nbsp; TIPS is associated with HE in up to 35% of patients due to (NH<font size=\"2\"><sub>3</sub></font>-rich) blood bypassing the liver.</p><p><strong>Educational objective:</strong><br>Patients with hepatic encephalopathy on diuretics can develop low intravascular volume despite having total volume overload, leading to a metabolic alkalosis with associated hypokalemia.&nbsp; Treatment includes volume resuscitation and repletion of hypokalemia in addition to serum ammonia-lowering medications (eg, lactulose).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 1625,
            "topic": "Hepatic Encephalopathy",
            "titleId": 1625,
            "title": "Hepatic Encephalopathy",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Dietary protein restriction",
                    "choiceNumber": 1,
                    "correctTaken": 1225,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Low-dose lorazepam",
                    "choiceNumber": 2,
                    "correctTaken": 553,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Oral neomycin",
                    "choiceNumber": 3,
                    "correctTaken": 2037,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Repletion of serum potassium",
                    "choiceNumber": 4,
                    "correctTaken": 6509,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Transjugular intrahepatic portosystemic shunt",
                    "choiceNumber": 5,
                    "correctTaken": 1404,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1170,1594,true,-1,1*2019,2147,true,-1,1*2337,2470,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25042402",
                    "mediaDataId": 0,
                    "title": "Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25042402",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 159,
            "othersAvgTimeSpent": 65,
            "notes": null,
            "peopleTaken": 11728,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 55,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1533,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 10,
            "questionId": 2914,
            "questionIndex": 2914,
            "questionText": "<p>A 68-year-old man is brought to the emergency department due to 2 days of progressive confusion and lethargy.&nbsp; His symptoms started approximately 4 days ago with malaise, nausea, and vomiting.&nbsp; The patient has hypertension and chronic back pain due to spinal stenosis.&nbsp; Laminectomy 4 years ago provided limited symptom improvement.&nbsp; The patient&#39;s medications include daily losartan and as-needed hydrocodone-acetaminophen.&nbsp; His wife says that for the past 2 weeks he has been taking additional acetaminophen for a severe toothache.&nbsp; The patient smokes a pack of cigarettes and drinks 2 shots of whiskey daily.&nbsp; He has a remote history of intravenous drug abuse.&nbsp; His blood pressure is 110/60 mm Hg, pulse is 108/min, and BMI is 32 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; The patient is sleepy but wakes when spoken to and follows instructions.&nbsp; He is oriented to person and place.&nbsp; There is mild scleral icterus.&nbsp; Cardiopulmonary examination is unremarkable, and a smooth and tender liver edge is palpable 3 cm below the right costal margin.&nbsp; The patient has a mild flapping tremor of both hands.&nbsp; Laboratory results are as follows:</p><blockquote><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"425\"><tbody><tr><td colspan=\"2\">Complete blood count</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Hematocrit</td><td>42%</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td>160,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td>9000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" height=\"15\"></td></tr><tr><td colspan=\"2\">Serum chemistry</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Blood urea nitrogen</td><td>32 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Creatinine</td><td>1.9 mg/dL</td></tr><tr><td colspan=\"2\" height=\"15\"></td></tr><tr><td colspan=\"2\">Liver function studies</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Total bilirubin</td><td>3.3 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Alkaline phosphatase</td><td>220 U/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Aspartate aminotransferase</td><td>3207 U/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Alanine aminotransferase</td><td>4180 U/L</td></tr><tr><td colspan=\"2\" height=\"15\"></td></tr><tr><td>INR</td><td>1.6 (normal 0.8-1.2)</td></tr></tbody></table></blockquote><p>Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><div id=\"div_t80870\"><table class=\"table-default-style table-header-footer-style\" style=\"width:100%\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Acute liver failure</strong></p></td></tr><tr><td><p align=\"center\"><strong>Etiology</strong></p></td><td><ul><li>Viral hepatitis (eg, HSV; CMV; hepatitis A, B, D, E)</li><li>Drug toxicity (eg, acetaminophen overdose, idiosyncratic)</li><li>Ischemia (eg, shock liver, Budd-Chiari syndrome)</li><li>Autoimmune hepatitis</li><li>Wilson disease</li><li>Malignant infiltration</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical presentation</strong></p></td><td><ul><li>Generalized symptoms (eg, fatigue, lethargy, anorexia, nausea)</li><li>Right upper quadrant abdominal pain</li><li>Pruritus &amp; jaundice due to hyperbilirubinemia</li><li>Renal insufficiency</li><li>Thrombocytopenia</li><li>Hypoglycemia</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnostic requirements</strong></p></td><td><ul><li>Severe acute liver injury (ALT &amp; AST often &gt;1,000 U/L)</li><li>Signs of hepatic encephalopathy (eg, confusion, asterixis)</li><li>Synthetic liver dysfunction (INR &ge;1.5)</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>ALT</strong> = alanine aminotransferase; <strong>AST</strong> = aspartate aminotransferase; <strong>CMV</strong> = cytomegalovirus; <strong>HSV</strong> = herpes simplex virus; <strong>INR</strong> = international normalized ratio.</p></td></tr></tbody></table></div></p><p>This patient has <strong>acute liver failure (ALF)</strong> likely due to <strong>acetaminophen toxicity</strong> in the setting of chronic alcohol use.&nbsp; Diagnosis of ALF requires the triad of <strong>elevated aminotransferases</strong> (markedly elevated in this patient), signs of <strong>hepatic encephalopathy</strong> (confusion, somnolence, and flapping tremor consistent with asterixis in this patient), and <strong>synthetic liver dysfunction</strong> (evidenced by <strong>INR <u>&gt;</u>1.5</strong>).&nbsp; Cirrhosis or underlying liver disease should not be present.</p><p>Acetaminophen toxicity is the most common cause of ALF in many developed countries and can be seen in intentional overdose (suicide attempt) or accidental overdose in patients taking multiple sources of acetaminophen (such as this patient).&nbsp; Toxicity results from overproduction of the toxic metabolite <strong><em>N</em>-acetyl-<em>p</em>-benzoquinone imine (NAPQI)</strong>, which leads to hepatic necrosis.&nbsp; NAPQI is normally safely detoxified through <strong>glucuronidation</strong> in the liver, but this pathway becomes overwhelmed in overdose.&nbsp; <strong>Chronic alcohol use</strong> is thought to potentiate acetaminophen hepatotoxicity by depleting glutathione levels and impairing the glucuronidation process.&nbsp; On the other hand, <em>N</em>-acetylcysteine increases glutathione levels and binds to NAPQI, so it is an effective antidote for acetaminophen overdose when given early.</p><p>Acute <strong>renal insufficiency</strong> is common in ALF, especially when acetaminophen induced, due to the drug&#39;s direct renal tubular toxicity.&nbsp; <strong>Hyperbilirubinemia</strong> is common as well, but acetaminophen hepatotoxicity is characterized by relatively low serum bilirubin compared with that in other etiologies of ALF.</p><p><strong>(Choice A)</strong>&nbsp; Acute alcoholic hepatitis typically causes mild to moderate aminotransferase elevation (&lt;500 U/L) in patients who drink heavily (&gt;100 g/day).&nbsp; The AST/ALT ratio is usually &gt;2:1.</p><p><strong>(Choice B)</strong>&nbsp; Hepatitis C causes chronic hepatitis and may lead to cirrhosis but is not typically associated with ALF.&nbsp; Hepatitis A, B, D, and E are more typical causes of ALF.</p><p><strong>(Choice C)</strong>&nbsp; Ischemic hepatitis can result from severe hypotension (eg, shock liver) or Budd-Chiari syndrome (hepatic vein thrombosis) and is a potential cause of ALF.&nbsp; This patient has not had significant hypotension and lacks right upper quadrant pain, which is typically severe in Budd-Chiari syndrome.</p><p><strong>(Choices D and F)</strong>&nbsp; Nonalcoholic steatohepatitis is a chronic condition that is associated with metabolic syndrome and may lead to liver cirrhosis.&nbsp; Both nonalcoholic steatohepatitis and cirrhosis are characterized by normal to moderately elevated aminotransferase levels, and elevation &gt;1000 U/L is not consistent with either diagnosis.</p><p><strong>Educational objective:</strong><br>Acute liver failure (ALF) is characterized by elevated aminotransferases, encephalopathy, and INR <u>&gt;</u>1.5.&nbsp; Acetaminophen toxicity is a common cause of ALF that may be potentiated by chronic alcohol use.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 21090,
            "topic": "Acute liver failure",
            "titleId": 21090,
            "title": "Acute liver failure",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acute alcoholic hepatitis",
                    "choiceNumber": 1,
                    "correctTaken": 331,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hepatitis C infection",
                    "choiceNumber": 2,
                    "correctTaken": 853,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ischemic hepatitis",
                    "choiceNumber": 3,
                    "correctTaken": 299,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Liver cirrhosis",
                    "choiceNumber": 4,
                    "correctTaken": 862,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Medication-induced liver injury",
                    "choiceNumber": 5,
                    "correctTaken": 9036,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Nonalcoholic steatohepatitis",
                    "choiceNumber": 6,
                    "correctTaken": 69,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1229,1290,true,-1,1*1533,2102,true,-1,1*2103,2233,true,-1,1*2607,2711,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22447259",
                    "mediaDataId": 0,
                    "title": "Acute liver failure.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22447259",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "16317692",
                    "mediaDataId": 0,
                    "title": "Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/16317692",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "11929388",
                    "mediaDataId": 0,
                    "title": "Influence of acute and chronic alcohol intake on the clinical course and outcome in acetaminophen overdose.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/11929388",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 171,
            "othersAvgTimeSpent": 88,
            "notes": null,
            "peopleTaken": 11450,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 79,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1493,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 11,
            "questionId": 17253,
            "questionIndex": 18705,
            "questionText": "<p>A 54 year-old-man comes to the office due to a 3-day history of fever, malaise, and loss of appetite.&nbsp; The patient has not experienced weight loss, headache, cough, dyspnea, rash, vomiting, or bloody stools.&nbsp; Medical history is unremarkable, and he takes no medications.&nbsp; He lives in an overcrowded homeless shelter, drinks several beers a day, and intermittently smokes marijuana but denies other illicit drug use.&nbsp; The patient is not sexually active and has not traveled outside of the United States.&nbsp; Family history is unremarkable.&nbsp; Temperature is 38.1 C (100.6 F), blood pressure is 135/80 mm Hg, and pulse is 85/min.&nbsp; Scleral icterus is absent.&nbsp; Cardiopulmonary and skin examinations are unremarkable.&nbsp; The abdomen is soft and nondistended.&nbsp; Hepatomegaly is present.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td style=\"vertical-align:middle;\">14.2 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td style=\"vertical-align:middle;\">355,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td style=\"vertical-align:middle;\">12,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Liver function studies</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Total bilirubin</td><td style=\"vertical-align:middle;\">1.2 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Alkaline phosphatase</td><td style=\"vertical-align:middle;\">150 U/L</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Aspartate aminotransferase (SGOT)</td><td style=\"vertical-align:middle;\">2,580 U/L</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Alanine aminotransferase (SGPT)</td><td style=\"vertical-align:middle;\">4,205 U/L</td></tr></tbody></table><p>Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t61546\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Hepatitis A</strong></p></td></tr><tr><td><p align=\"center\"><strong>Transmission<br />&amp; risk factors</strong></p></td><td><ul><li>Fecal-oral transmission</li><li>Poor sanitation/hygiene, travel to endemic areas</li><li>Contaminated food &amp; water</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical<br />presentation</strong></p></td><td><ul><li>Fever, nausea, right upper quadrant pain</li><li>Jaundice, hepatomegaly</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnostic<br />testing</strong></p></td><td><ul><li>Elevated liver transaminases (&gt;1,000&nbsp;U/L)</li><li>Anti&ndash;hepatitis A serology</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Supportive/expectant</li><li>Spontaneous recovery in most patients</li></ul></td></tr></tbody></table></div><p>This patient has fever, fatigue, and anorexia associated with severely elevated liver aminotransferases.&nbsp; These features are likely due to <strong>hepatitis A</strong>.&nbsp; Hepatitis A virus (HAV) is <strong>fecal-orally</strong> transmitted; outbreaks have been linked to contaminated water and food (eg, shellfish), as well as to <strong>overcrowded homeless shelters</strong>.&nbsp; Other groups at increased risk include international travelers, men who have sex with men, and illicit drug users.</p><p>Symptoms of hepatitis A develop abruptly.&nbsp; Initial symptoms include nausea, vomiting, anorexia, fever, and right upper quadrant pain.&nbsp; A few days later, dark urine (bilirubinuria) and/or pale stools (lacking bilirubin pigment) may be seen.&nbsp; These are usually followed by jaundice and pruritus (40%-70% of cases).&nbsp; Jaundice typically peaks within 2 weeks.</p><p><strong>Aminotransferases</strong> rise early in the disease process, with aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels often exceeding 1,000 U/L.&nbsp; Bilirubin and alkaline phosphatase levels rise several days later.&nbsp; The diagnosis is confirmed by <strong>anti-HAV IgM</strong>.&nbsp; Treatment for acute hepatitis A is supportive, and complete recovery is common.&nbsp; Postexposure prophylaxis (eg, vaccine, hepatitis A immunoglobulin) should be given to close contacts of infected patients.</p><p><strong>(Choice A)</strong>&nbsp; Acute cholangitis is an ascending infection associated with biliary obstruction (eg, choledocholithiasis, biliary stricture).&nbsp; Most patients are quite ill and have elevated alkaline phosphatase and significant direct hyperbilirubinemia.&nbsp; A significant hepatocellular injury pattern is uncommon.</p><p><strong>(Choice B)</strong>&nbsp; Acute cholecystitis results from cystic duct obstruction.&nbsp; Although fever may occur, most patients have right upper quadrant pain, and AST and ALT levels are typically &lt;1,000 U/L.</p><p><strong>(Choice C)</strong>&nbsp; Concurrent alcohol use can worsen hepatitis A.&nbsp; However, hepatic transaminase levels in isolated alcoholic hepatitis are rarely &gt;500 U/L and characteristically have an AST/ALT ratio of 2:1.</p><p><strong>(Choice D)</strong>&nbsp; Congestive hepatopathy results from impaired venous drainage of the liver, usually in the setting of right-sided heart failure.&nbsp; Severe elevations in transaminases can occur, but other features of heart failure (eg, dyspnea, jugular venous distension) would usually be present.&nbsp; Fever and leukocytosis are atypical.</p><p><strong>(Choice F)</strong>&nbsp; Locally invasive pancreatic cancer can obstruct the biliary tree, leading to jaundice and direct hyperbilirubinemia.&nbsp; Although mild elevations in AST and ALT can occur, levels &gt;1,000 are atypical.</p><p><strong>Educational objective:</strong><br>Hepatitis A presents acutely with fever, malaise, anorexia, nausea, hepatomegaly, and, sometimes, jaundice.&nbsp; Severe elevations in hepatic transaminases (&gt;1,000 U/L) occur early in the disease process, whereas bilirubin and alkaline phosphatase levels may increase several days later.&nbsp; The virus has fecal-oral transmission, and outbreaks have been linked to contaminated water or food, as well as to overcrowded homeless shelters.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 7127,
            "topic": "Hepatitis a",
            "titleId": 7127,
            "title": "Hepatitis a",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acute cholangitis",
                    "choiceNumber": 1,
                    "correctTaken": 965,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Acute cholecystitis",
                    "choiceNumber": 2,
                    "correctTaken": 385,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Alcoholic hepatitis",
                    "choiceNumber": 3,
                    "correctTaken": 3243,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Congestive hepatitis",
                    "choiceNumber": 4,
                    "correctTaken": 1807,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hepatitis A infection",
                    "choiceNumber": 5,
                    "correctTaken": 14647,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pancreatic cancer",
                    "choiceNumber": 6,
                    "correctTaken": 116,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1369,1437,true,-1,1*1563,1686,true,-1,1*2529,2676,true,-1,1*739,853,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23198670",
                    "mediaDataId": 0,
                    "title": "Hepatitis A.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23198670",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 73,
            "othersAvgTimeSpent": 78,
            "notes": null,
            "peopleTaken": 21163,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 69,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 871,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 12,
            "questionId": 14663,
            "questionIndex": 16078,
            "questionText": "<p>A 54-year-old woman comes to the office due to fatigue and weight loss.&nbsp; Over the past 3 months, she has unintentionally lost 10 kg (22 lb).&nbsp; The patient has a long-standing history of obesity, hypertension, dyslipidemia, and type 2 diabetes mellitus.&nbsp; She does not use tobacco, alcohol, or recreational drugs.&nbsp; Temperature is 36.9 C (98.4 F), blood pressure is 140/87 mm Hg, pulse is 80/min, and respirations are 16/min.&nbsp; BMI is 35 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; The abdomen is soft, the flanks are full, and shifting dullness is present.&nbsp; Mild right upper quadrant discomfort occurs on palpation.&nbsp; Trace edema is present in the lower extremities bilaterally.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"3\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"padding-left: 2em;\">Hemoglobin</td><td style=\"vertical-align:middle;\">11.6 g/dL</td><td style=\"vertical-align:middle;\"></td></tr><tr><td style=\"padding-left: 2em;\">Platelets</td><td style=\"vertical-align:middle;\">105,000/mm<font size=\"2\"><sup>3</sup></font></td><td style=\"vertical-align:middle;\"></td></tr><tr><td style=\"padding-left: 2em;\">Leukocytes</td><td style=\"vertical-align:middle;\">9,000/mm<font size=\"2\"><sup>3</sup></font></td><td style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"3\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"3\" style=\"vertical-align:middle;\">Liver function studies</td></tr><tr><td style=\"padding-left: 2em;\">Albumin</td><td style=\"vertical-align:middle;\">2.5 g/dL</td><td style=\"vertical-align:middle;\"></td></tr><tr><td style=\"padding-left: 2em;\">Total bilirubin</td><td style=\"vertical-align:middle;\">2.3 mg/dL</td><td style=\"vertical-align:middle;\"></td></tr><tr><td style=\"padding-left: 2em;\">Alkaline phosphatase</td><td style=\"vertical-align:middle;\">370 U/L</td><td style=\"vertical-align:middle;\"></td></tr><tr><td style=\"padding-left: 2em;\">Aspartate aminotransferase (SGOT)</td><td style=\"vertical-align:middle;\">134 U/L</td><td style=\"vertical-align:middle;\"></td></tr><tr><td style=\"padding-left: 2em;\">Alanine aminotransferase (SGPT)</td><td style=\"vertical-align:middle;\">124 U/L</td><td style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td><td style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Blood, plasma, and serum</td><td style=\"vertical-align:middle;\"></td></tr><tr><td style=\"padding-left: 2em;\">Alpha-fetoprotein, serum</td><td style=\"vertical-align:middle;\">12 ng/mL</td><td style=\"vertical-align:middle;\">(normal: 0-20)</td></tr></tbody></table><p>Abdominal ultrasonography is notable for a 3-cm hepatic nodule in the right lobe.</p><p>Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient with <strong>unintentional weight loss</strong> has evidence of <strong>decompensated liver failure</strong>, presenting as <strong>new-onset ascites</strong> (shifting abdominal dullness) and impaired hepatic function (eg, hypoalbuminemia, elevated liver enzymes, thrombocytopenia).&nbsp; Abdominal ultrasonography also reveals a <strong>hepatic nodule</strong>.&nbsp; These findings are concerning for <strong>hepatocellular carcinoma (HCC)</strong>.</p><p><strong>Cirrhosis</strong> greatly increases HCC risk (eg, ~1%-8%/year).&nbsp; Although cirrhosis frequently occurs with chronic alcohol use or hepatitis, it can also arise from <strong>nonalcoholic fatty liver disease</strong> (NAFLD), which is likely in this patient with <strong>metabolic syndrome</strong> (eg, obesity, hypertension, dyslipidemia, type 2 diabetes mellitus).&nbsp; Liver enzymes can be elevated or normal in cirrhosis; although NAFLD is associated with an AST/ALT ratio of &lt;1, reversal of this ratio can occur with the onset of cirrhosis.</p><p>Both cirrhosis and HCC can remain <strong>asymptomatic</strong> until complications (eg, ascites, variceal bleeding, HCC) develop, as seen in this patient.&nbsp; On occasion, a palpable liver nodule may be revealed in patients with HCC who have cachexia.&nbsp; Although an elevated alpha-fetoprotein (AFP) (a glycoprotein produced by the fetal liver and yolk sac) helps confirm HCC, a <strong>normal AFP does not rule out HCC</strong> because it can be normal in up to half of patients with this disease.&nbsp; An additional imaging study (CT scan, MRI) is typically performed to further characterize a suspicious nodule.</p><p><strong>(Choices A and B)</strong>&nbsp; Focal nodular hyperplasia and hepatic adenoma are benign liver lesions also presenting with solitary liver nodules; hepatic adenomas are associated with excess estrogen (eg, oral contraceptive use, obesity).&nbsp; Neither condition is associated with decompensated liver failure.</p><p><strong>(Choice D)</strong>&nbsp; Hydatid hepatic cysts caused by <em>Echinococcus</em> tapeworm infection are typically asymptomatic unless lesions are very large (eg, &gt;10 cm).&nbsp; Ultrasonography is highly sensitive and shows an anechoic, round cyst rather than a nodule.</p><p><strong>(Choice E)</strong>&nbsp; Pyogenic liver abscess is most common in the setting of biliary infection or bowel perforation.&nbsp; Patients typically have fever, abdominal pain, and leukocytosis, features absent in this patient.</p><p><strong>Educational objective:</strong><br>Decompensated liver failure (eg, weight loss, new-onset ascites) and a liver nodule are frequent presenting signs of hepatocellular carcinoma; alpha-fetoprotein levels may be normal or elevated.&nbsp; Cirrhosis is the most common risk factor and can arise from nonalcoholic fatty liver disease in patients with metabolic syndrome.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 7162,
            "topic": "Hepatocellular cancer",
            "titleId": 7162,
            "title": "Hepatocellular cancer",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Focal nodular hyperplasia",
                    "choiceNumber": 1,
                    "correctTaken": 738,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hepatic adenoma",
                    "choiceNumber": 2,
                    "correctTaken": 1419,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hepatocellular carcinoma",
                    "choiceNumber": 3,
                    "correctTaken": 2693,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hydatid cyst",
                    "choiceNumber": 4,
                    "correctTaken": 201,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pyogenic liver abscess",
                    "choiceNumber": 5,
                    "correctTaken": 74,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "779,898,true,-1,1*1607,1699,true,-1,1*1913,2005,true,-1,1*1132,1470,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29307467",
                    "mediaDataId": 0,
                    "title": "Hepatocellular carcinoma.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29307467",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 177,
            "othersAvgTimeSpent": 111,
            "notes": null,
            "peopleTaken": 5125,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 53,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 678,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 13,
            "questionId": 17309,
            "questionIndex": 18763,
            "questionText": "<p>A 34-year-old man comes to the emergency department for right upper quadrant abdominal pain.&nbsp; The pain started abruptly 24 hours ago and is described as constant, severe, and progressive.&nbsp; The patient was hospitalized 6 months ago for similar symptoms that were resolved with antibiotics.&nbsp; Review of systems is positive for occasional bloody stools.&nbsp; There is no relevant family history, and the patient does not use tobacco, alcohol, or recreational drugs.&nbsp; Temperature is 39.8 C (103.6 F), blood pressure is 90/50, pulse is 120/min, and respirations are 22/min.&nbsp; The patient is lethargic and difficult to arouse.&nbsp; Scleral icterus is present.&nbsp; Cardiopulmonary examination is unremarkable.&nbsp; The abdomen is tender to palpation in the right upper quadrant.&nbsp; Laboratory evaluation reveals the following:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"3\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td style=\"vertical-align:middle;\">14.2 g/dL</td><td style=\"vertical-align:middle;\"></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td style=\"vertical-align:middle;\">455,000/mm<font size=\"2\"><sup>3</sup></font></td><td style=\"vertical-align:middle;\"></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td style=\"vertical-align:middle;\">17,200/mm<font size=\"2\"><sup>3</sup></font></td><td style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"3\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"3\" style=\"vertical-align:middle;\">Liver function studies</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Total bilirubin</td><td style=\"vertical-align:middle;\">6.2 mg/dL</td><td style=\"vertical-align:middle;\"></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Alkaline phosphatase</td><td style=\"vertical-align:middle;\">854 U/L</td><td style=\"vertical-align:middle;\"></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Aspartate aminotransferase (SGOT)</td><td style=\"vertical-align:middle;\">108 U/L</td><td style=\"vertical-align:middle;\"></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Alanine aminotransferase (SGPT)</td><td style=\"vertical-align:middle;\">142 U/L</td><td style=\"vertical-align:middle;\"></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Lipase</td><td style=\"vertical-align:middle;\">20 U/L</td><td style=\"vertical-align:middle;\"></td></tr></tbody></table><p>Right upper quadrant ultrasound is normal.&nbsp; Which of the following is the most likely cause of this patient&#39;s presentation?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t55618\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Primary sclerosing cholangitis</strong></p></td></tr><tr><td><p align=\"center\" style=\"margin-left:.1in;\"><strong>Clinical features</strong></p></td><td><ul><li>Asymptomatic initially; fatigue &amp; pruritus with progressive disease</li><li>Associated with IBD, particularly ulcerative colitis</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory &amp; imaging results</strong></p></td><td><ul><li>Cholestasis (&#8593; ALP, GGT, bilirubin)</li><li>Multifocal strictures/dilation of bile ducts on MRCP</li></ul></td></tr><tr><td><p align=\"center\" style=\"margin-left:.1in;\"><strong>Complications</strong></p></td><td><ul><li>Cholangitis, cholangiocarcinoma, colon cancer</li><li>Fat-soluble vitamin deficiencies</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>ALP</strong> = alkaline phosphatase; <strong>GGT</strong> = &#947;-glutamyl transferase; <strong>IBD</strong> = inflammatory bowel disease; <strong>MRCP</strong> = MR cholangiopancreatography.</p></td></tr></tbody></table></div><p>This patient with right upper quadrant pain, fever, jaundice, hypotension, and altered mental status (ie, Reynolds pentad) has the typical features of <strong>acute cholangitis</strong>.&nbsp; Acute cholangitis is an infection of the extrahepatic biliary system that usually occurs due to <strong>biliary obstruction</strong> (eg, bile stone, malignancy, <strong>stricture</strong>), which predisposes patients to bacterial invasion of the normally sterile biliary tree.&nbsp; In a young adult male with a history of hematochezia, the most likely etiology of recurrent acute cholangitis (eg, similar symptoms in the past)&nbsp;is a biliary stricture due to <strong>primary sclerosing cholangitis</strong> (PSC).</p><p>PSC is a chronic disease characterized by <strong>fibrosis and stricturing</strong> of the medium and large intra- and extrahepatic bile ducts.&nbsp; This promotes <strong>cholestasis</strong> (elevated alkaline phosphatase, hyperbilirubinemia) and <strong>obstruction</strong>.&nbsp; PSC usually affects men and is associated with <strong>ulcerative colitis</strong>, which explains this patient&#39;s hematochezia.&nbsp; Patients may have normal ultrasonography because intrahepatic bile ducts are not easily visible.&nbsp; Magnetic resonance cholangiopancreatography overcomes this limitation and is the preferred test to confirm the diagnosis in these patients.</p><p>Management&nbsp;of PSC includes endoscopic interventions for&nbsp;strictures, therapy for coexisting&nbsp;ulcerative colitis, antibiotics for cholangitis (with some patients maintained on longterm antibiotic therapy), and, in some cases, ursodeoxycholic acid.</p><p><strong>(Choice A)</strong>&nbsp; Annular pancreas is a congenital disorder that results in a ringlike pancreas that encircles the duodenum.&nbsp; It can cause duodenal obstruction (eg, vomiting, pain, early satiety), but acute cholangitis is atypical.</p><p><strong>(Choice B)</strong>&nbsp; Cholangiocarcinoma is a risk factor for developing acute cholangitis and may develop as a complication of PSC; however, it usually develops in older patients (eg, age &gt;50), and unexpected weight loss is typical.</p><p><strong>(Choice C)</strong>&nbsp; Chronic pancreatitis presents with recurrent abdominal pain, vomiting and steatorrhea.&nbsp; It typically occurs in patients with risk factors (eg, smoking, alcohol use, family history); it is not associated with acute cholangitis.</p><p><strong>(Choice D)</strong>&nbsp; Pancreatic divisum is a congenital disorder that results in the presence of a dorsal and ventral (rather than singular) pancreatic duct.&nbsp; Although it can cause recurrent acute pancreatitis (eg, abdominal pain, vomiting, elevated lipase), acute cholangitis is not expected.</p><p><strong>(Choice E)</strong>&nbsp; Primary biliary cholangitis (PBC) results from an immune response against the intrahepatic bile ducts can also present with cholestasis (eg, elevated alkaline phosphatase, jaundice, pruritus).&nbsp; However, it is much more common in women (~90% of cases) and is only rarely associated with ulcerative colitis.&nbsp; In addition, acute cholangitis (usually caused by obstruction of the extrahepatic bile ducts) is rare in PBC (which affects the intrahepatic bile ducts).</p><p><strong>Educational objective:</strong><br>Primary sclerosing cholangitis is characterized by fibrosis and stricturing of the medium and large intra- and extrahepatic bile ducts, promoting cholestasis and acute cholangitis.&nbsp; It occurs most commonly in men and is strongly associated with ulcerative colitis.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 20379,
            "topic": "Primary Sclerosing Cholangitis",
            "titleId": 20379,
            "title": "Primary Sclerosing Cholangitis",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "6",
            "userAnswer": "6",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Annular pancreas",
                    "choiceNumber": 1,
                    "correctTaken": 809,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cholangiocarcinoma",
                    "choiceNumber": 2,
                    "correctTaken": 1032,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Chronic pancreatitis",
                    "choiceNumber": 3,
                    "correctTaken": 946,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pancreatic divisum",
                    "choiceNumber": 4,
                    "correctTaken": 606,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Primary biliary cholangitis",
                    "choiceNumber": 5,
                    "correctTaken": 5162,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Primary sclerosing cholangitis",
                    "choiceNumber": 6,
                    "correctTaken": 12099,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "181,199,true,-1,1*241,254,true,-1,1*332,410,true,-1,1*539,661,true,-1,1*709,955,true,-1,1*1502,1741,true,-1,1*1742,1986,true,-1,1*1998,2176,true,-1,1*2224,2293,true,-1,1*2573,2630,true,-1,1*2687,2960,true,-1,1*3279,3433,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 177,
            "othersAvgTimeSpent": 86,
            "notes": null,
            "peopleTaken": 20654,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 59,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1326,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 14,
            "questionId": 4321,
            "questionIndex": 4321,
            "questionText": "<p>A 46-year-old man comes to the office due to a sensation of right upper quadrant fullness.&nbsp; The patient has had obesity since early adolescence.&nbsp; Medical history includes type 2 diabetes mellitus and hypertension.&nbsp; Current medications include metformin, candesartan, and hydrochlorothiazide.&nbsp; The patient does not use tobacco, alcohol, or recreational drugs.&nbsp; His father has type 2 diabetes mellitus.&nbsp; Temperature is 36.7 C (98 F), blood pressure is 138/90 mm Hg, pulse is 72/min, and respirations are 16/min.&nbsp; BMI is 36 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Physical examination is notable for acanthosis nigricans over the neck creases and hepatomegaly.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Albumin</td><td style=\"vertical-align:middle;\">4.0 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">Total bilirubin</td><td style=\"vertical-align:middle;\">1.0 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">Direct bilirubin</td><td style=\"vertical-align:middle;\">0.3 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">Alkaline phosphatase</td><td style=\"vertical-align:middle;\">100 U/L</td></tr><tr><td style=\"vertical-align:middle;\">Aspartate aminotransferase (SGOT)</td><td style=\"vertical-align:middle;\">122 U/L</td></tr><tr><td style=\"vertical-align:middle;\">Alanine aminotransferase (SGPT)</td><td style=\"vertical-align:middle;\">131 U/L</td></tr><tr><td style=\"vertical-align:middle;\">Blood glucose (fasting)</td><td style=\"vertical-align:middle;\">168 mg/dL</td></tr></tbody></table><p>Viral hepatitis serologies, antimitochondrial antibodies, antinuclear antibodies, serum ceruloplasmin, and transferrin saturation are normal.&nbsp; Which of the following is the most likely pathophysiologic mechanism responsible for this patient&#39;s increased liver enzymes?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t36385\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Metabolic dysfunction-associated steatotic liver disease</strong></p></td></tr><tr><td><p align=\"center\"><strong>Definition</strong></p></td><td><ul><li>Hepatic steatosis on imaging or biopsy</li><li>Exclusion of other etiologies (eg, alcohol, hepatitis&nbsp;C, glucocorticoids)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical<br />features</strong></p></td><td><ul><li>Mostly asymptomatic</li><li>Metabolic syndrome*</li><li>AST/ALT ratio &lt;1</li><li>Ultrasonographic findings: &uarr; echogenicity (steatosis), coarse echotexture (fibrosis)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Weight loss (eg, diet modification, exercise)</li><li>Consider bariatric surgery if BMI &ge;35 kg/m<sup>2</sup></li></ul></td></tr><tr><td><p align=\"center\"><strong>Prognosis</strong></p></td><td><ul><li>Hepatic fibrosis associated with increased risk for cirrhosis &amp; liver-related death</li></ul></td></tr><tr><td colspan=\"2\"><p>*Obesity, diabetes mellitus, dyslipidemia, hypertension.</p><p><strong>ALT</strong> = alanine aminotransferase;<strong> AST</strong> = aspartate aminotransferase.</p></td></tr></tbody></table></div><p>This patient&#39;s hepatocellular injury in the absence of heavy alcohol use or other etiologies (eg, viral hepatitis, hemochromatosis) is most consistent with <strong>nonalcoholic fatty liver disease</strong> (NAFLD).&nbsp; Affected patients typically have coexisting <strong>metabolic syndrome</strong> (eg, central obesity, diabetes mellitus, hyperlipidemia, hypertension).&nbsp; NAFLD can range from bland steatosis to inflammation and hepatocyte injury (steatohepatitis) to fibrosis and cirrhosis.</p><p>NAFLD is likely due to toxic lipid accumulation in the liver.&nbsp; The <a href=\"39610\">pathogenesis</a> appears to involve <strong>insulin resistance</strong>, which <strong>increases peripheral lipolysis</strong> (in adipocytes) and triglyceride synthesis <strong>(Choice A)</strong>, leading to increased <strong>hepatic accumulation of fatty acids</strong> and triglycerides.&nbsp; On histologic examination, hepatocytes show macrovesicular <a href=\"58737\">fat deposition</a> with peripherally displaced nuclei.&nbsp; In addition, hepatic free fatty acid (FFA) accumulation:</p><ul><li><p>increases <strong>free radical</strong> and <strong>proinflammatory cytokine</strong> generation, which can lead to inflammation and hepatocyte injury (steatohepatitis).</p></li><li><p>worsens insulin resistance by impairing insulin-dependent glucose uptake and increasing hepatic gluconeogenesis.</p></li></ul><p>Insulin resistance is also associated with impaired FFA oxidation (in the liver) and clearance (from the liver, due to decreased VLDL production).</p><p><strong>(Choice B)</strong>&nbsp; Some patients with type 2 diabetes have increased glucagon production.&nbsp; Although glucagon increases gluconeogenesis and glycogenolysis, it does not have a role in hepatic fat accumulation.</p><p><strong>(Choice C)</strong>&nbsp; Cushing syndrome is associated with increased endogenous glucocorticoid production and can contribute to insulin resistance and NAFLD, but it would be unlikely in this patient with near life-long obesity.</p><p><strong>(Choice D)</strong>&nbsp; Hepatic glycogen synthesis is usually decreased in type 2 diabetes mellitus and does not have a role in hepatic steatosis.</p><p><strong>Educational objective:</strong><br>Insulin resistance is thought to have a major role in nonalcoholic fatty liver disease, which frequently coexists with metabolic syndrome.&nbsp; Insulin resistance increases peripheral lipolysis in adipocytes, leading to increased hepatic accumulation of free fatty acids.&nbsp; Hepatic fatty acid accumulation increases free radical and proinflammatory cytokine generation, resulting in tissue damage (eg, steatohepatitis).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 9995,
            "topic": "Nonalcoholic fatty liver disease",
            "titleId": 9995,
            "title": "Nonalcoholic fatty liver disease",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Decreased peripheral lipolysis",
                    "choiceNumber": 1,
                    "correctTaken": 2827,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Glucagon overproduction",
                    "choiceNumber": 2,
                    "correctTaken": 662,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increased glucocorticoid production",
                    "choiceNumber": 3,
                    "correctTaken": 538,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increased hepatic glycogen synthesis",
                    "choiceNumber": 4,
                    "correctTaken": 2878,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Insulin resistance",
                    "choiceNumber": 5,
                    "correctTaken": 8303,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "147,186,true,-1,1*244,260,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": true,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "624",
                    "mediaDataId": 0,
                    "title": "Evaluation of abnormal liver function tests (LFTs)",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "716",
                    "mediaDataId": 0,
                    "title": "Metabolic dysfunction-associated steatotic liver disease (MASLD) (formerly NAFLD)",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "33334622",
                    "mediaDataId": 0,
                    "title": "Epidemiology, pathogenesis, diagnosis and emerging treatment of nonalcoholic fatty liver disease.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/33334622",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 111,
            "othersAvgTimeSpent": 72,
            "notes": null,
            "peopleTaken": 15208,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 55,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1301,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 15,
            "questionId": 2895,
            "questionIndex": 2895,
            "questionText": "<p>A 24-year-old man is brought to the office by his parents due to hand shaking and involuntary movements, which have progressively worsened over the last 6 months.&nbsp; A year ago, he was diagnosed with depression and treated with fluoxetine for 5 months but stopped the medication and did not follow up with his psychiatrist.&nbsp; His medical history is otherwise unremarkable.&nbsp; The patient has smoked cigarettes intermittently in the past but does not drink alcohol or use illicit drugs.&nbsp; He dropped out of college and has worked as a delivery man for the last several years.&nbsp; Blood pressure is 122/82 mm Hg supine and 120/84 mm Hg standing.&nbsp; Physical examination reveals clear breath sounds and no cardiac murmurs.&nbsp; The liver is enlarged, firm, and nontender, and the spleen is not palpable.&nbsp; There is tremor of both hands that increases with activity.&nbsp; Occasional rapid, jerky contractions of the distal extremities are also seen.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td>Total bilirubin</td><td>1.9 mg/dL</td></tr><tr><td>Direct bilirubin</td><td>0.9 mg/dL</td></tr><tr><td>Alkaline phosphatase</td><td>31 U/L</td></tr><tr><td>Aspartate aminotransferase</td><td>276 U/L</td></tr><tr><td>Alanine aminotransferase</td><td>130 U/L</td></tr><tr><td>Prothrombin time</td><td>12.0 sec</td></tr></tbody></table><p>Viral hepatitis panel is negative.&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t32077\"><table class=\"table-default-style\" style=\"width:540px\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Wilson disease</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathogenesis</strong></p></td><td><ul><li>Autosomal recessive mutation of <em>ATP7B</em>&nbsp;&rarr; hepatic copper accumulation&nbsp;&rarr; leak from damaged hepatocytes&nbsp;&rarr; deposits in tissues (eg,&nbsp;basal ganglia, cornea)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical<br />findings</strong></p></td><td><ul><li>Hepatic (acute liver failure, chronic hepatitis, cirrhosis)</li><li>Neurologic (parkinsonism, gait disturbance, dysarthria)</li><li>Psychiatric (depression, personality changes, psychosis)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><ul><li>&darr;&nbsp;Ceruloplasmin&nbsp;&amp; &uarr;&nbsp;urinary copper excretion</li><li>Kayser-Fleischer rings on slit-lamp examination</li><li>&uarr;&nbsp;Copper content on liver biopsy</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Chelators (eg,&nbsp;D-penicillamine, trientine)</li><li>Zinc (interferes with copper absorption)</li></ul></td></tr></tbody></table></div><p>The combination of liver disease (eg, elevated liver enzyme results) and neuropsychiatric symptoms (eg, tremors, involuntary movements) in a young adult is highly suggestive of <strong>Wilson disease</strong> (WD, hepatolenticular degeneration), a rare, autosomal recessive disease most often identified in individuals age 5-35.&nbsp; It results from impaired <strong>copper</strong> transportation with resultant <strong>accumulation</strong> in tissues, including the liver and brain.&nbsp; In younger patients, liver disease predominates, whereas neurologic symptoms are more prominent in older patients.</p><p><strong>Liver dysfunction</strong> ranges from asymptomatic liver function abnormalities to hepatitis to cirrhosis.&nbsp; <strong>Neuropsychiatric symptoms</strong> include parkinsonism, dysarthria, choreoathetosis, ataxia, personality changes, and depression.&nbsp; Tremors can occur with activity or at rest.&nbsp; The diagnosis is suggested by low serum ceruloplasmin with increased urinary copper excretion or <a href=\"2562\">Kayser-Fleischer rings</a> (golden brown or greenish rings due to copper deposits in the cornea).</p><p>Treatment focuses on removing accumulated copper and preventing re-accumulation.&nbsp; First-line medications include copper chelators (eg, D-penicillamine, trientine).&nbsp; Oral zinc, which interferes with copper absorption, may be used for maintenance therapy.&nbsp; For patients with fulminant hepatic failure or drug-resistant disease, liver transplantation is curative.</p><p><strong>(Choice A)</strong>&nbsp; Alpha-1-antitrypsin deficiency (AATD) can result in obstructive lung disease, liver dysfunction (eg, cirrhosis), and skin disease.&nbsp; Patients who smoke are at very high risk of early onset emphysema, but this patient lacks any evidence of lung involvement, and AATD would not explain the neuropsychiatric symptoms.</p><p><strong>(Choice B)</strong>&nbsp; Hemochromatosis is characterized by iron overload.&nbsp; Common clinical manifestations include liver disease, hyperpigmentation, diabetes mellitus, arthropathy, and cardiac enlargement.</p><p><strong>(Choice C)</strong>&nbsp; Huntington disease is a genetic disorder with marked neuropsychiatric manifestations such as chorea, parkinsonism, dementia, and personality changes; however, there is no association with liver disease.&nbsp; Moreover, symptom onset usually occurs in midlife.</p><p><strong>(Choice D)</strong>&nbsp; Multiple system atrophy describes a series of neuromotor disorders that share a common set of symptoms, including parkinsonism, urogenital dysfunction (eg, erectile dysfunction), autonomic dysfunction (eg, orthostatic hypotension), and ataxia.</p><p><strong>(Choice E)</strong>&nbsp; Serotonin syndrome most commonly occurs within the first 24 hours of starting or adjusting the dose of a medication with serotonergic activity.&nbsp; It is associated with autonomic instability, agitation, diaphoresis, hyperreflexia, and clonus.</p><p><strong>Educational objective:</strong><br>Wilson disease is characterized by the combination of liver disease and neuropsychiatric symptoms that present in patients age 5-35.&nbsp; Liver dysfunction ranges from asymptomatic liver function abnormalities to cirrhosis.&nbsp; Neuropsychiatric symptoms include parkinsonism, dysarthria, choreoathetosis, ataxia, personality changes, and depression.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 19953,
            "topic": "Wilson disease",
            "titleId": 19953,
            "title": "Wilson disease",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "6",
            "userAnswer": "6",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Alpha-1-antitrypsin deficiency",
                    "choiceNumber": 1,
                    "correctTaken": 478,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hemochromatosis",
                    "choiceNumber": 2,
                    "correctTaken": 1696,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Huntington disease",
                    "choiceNumber": 3,
                    "correctTaken": 1877,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Multiple system atrophy",
                    "choiceNumber": 4,
                    "correctTaken": 350,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serotonin-reuptake inhibitor toxicity",
                    "choiceNumber": 5,
                    "correctTaken": 669,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Wilson disease",
                    "choiceNumber": 6,
                    "correctTaken": 11455,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "409,453,true,-1,1*588,628,true,-1,1*1176,1441,true,-1,1*2121,2139,true,-1,1*2494,2515,true,-1,1*2620,2676,true,-1,1*2795,3038,true,-1,1*3091,3193,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "350",
                    "mediaDataId": 0,
                    "title": "Wilson disease",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25755520",
                    "mediaDataId": 0,
                    "title": "A review and current perspective on Wilson disease.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25755520",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 69,
            "othersAvgTimeSpent": 78,
            "notes": null,
            "peopleTaken": 16525,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 69,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1073,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 16,
            "questionId": 2969,
            "questionIndex": 2969,
            "questionText": "<p>A 45-year-old man comes to the office due to progressive shortness of breath on exertion and fatigue for the past several weeks.&nbsp; Two years ago, the patient was diagnosed with alcoholic cirrhosis and esophageal varices after presenting with hematemesis.&nbsp; He underwent banding of the varices.&nbsp; Several months ago, the patient came to the office with massive ascites and a large-volume paracentesis was performed.&nbsp; His current medications include furosemide, spironolactone, and nadolol.&nbsp; He has had no alcohol for the past 2 years.&nbsp; The patient does not use tobacco or illicit drugs.&nbsp; Blood pressure is 114/72 mm Hg and pulse is 63/min.&nbsp; Pulse oximetry shows 95% on room air.&nbsp; There is no change in dyspnea on lying down or moving into an upright position.&nbsp; His neck veins are flat.&nbsp; Heart sounds are normal with no murmur or gallop.&nbsp; Dullness and decreased breath sounds are present on the right.&nbsp; Left-sided breath sounds are normal with no added sounds.&nbsp; The abdomen is moderately distended with shifting dullness.&nbsp; Bowel sounds are normal.&nbsp; Stool guaiac is negative.&nbsp; He has 1+ bilateral lower extremity pitting edema.&nbsp; Which of the following is the most likely cause of this patient&#39;s current symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<p>Patients with cirrhosis and portal hypertension frequently have abdominal ascites and peripheral edema due to low albumin levels and abnormal extracellular fluid volume regulation.&nbsp; A small number of these patients may also develop <strong>hepatic hydrothorax</strong>, a pleural effusion not due to underlying cardiac or pulmonary abnormalities.</p><p>Hepatic hydrothorax generally results in transudative <strong>pleural effusions</strong> and is thought to occur due to small <strong>defects</strong> in the diaphragm.&nbsp; These defects permit peritoneal fluid to pass into the pleural space, which occurs much more commonly on the <strong>right</strong> side due to the less muscular <strong>hemidiaphragm</strong>.&nbsp; Patients have dyspnea, cough, pleuritic chest pain, and hypoxemia.&nbsp; Diagnosis involves documentation of the effusion (eg, chest x-ray) and testing to exclude other causes (eg, thoracentesis, echocardiogram).</p><p>Treatment involves salt restriction and diuretic administration.&nbsp; Therapeutic thoracentesis could be attempted in patients with prominent symptoms.&nbsp; Chest tube placement should be avoided as it can result in large-volume protein, fluid, and electrolyte losses as well as other severe complications (eg, renal failure).&nbsp; The definitive option for treatment is liver transplantation, although this may not be appropriate for all patients depending on other factors.</p><p><strong>(Choice A)</strong>&nbsp; This patient&#39;s lack of other findings suggestive of heart failure (eg, increased jugular venous pressure, S3, bilateral crackles) makes alcoholic cardiomyopathy much less likely.</p><p><strong>(Choice B)</strong>&nbsp; Tense ascites can result in dyspnea and decrease the range of diaphragmatic excursion due to increased intraabdominal pressure, but this is unlikely to cause right-sided dullness and decreased breath sounds.</p><p><strong>(Choice D)</strong>&nbsp; Hepatopulmonary syndrome results from intrapulmonary vascular dilations in the setting of chronic liver disease.&nbsp; Patients frequently have evidence of platypnea (increased dyspnea while upright) or orthodeoxia (oxygen desaturation while upright).</p><p><strong>(Choices E and F)</strong>&nbsp; Although beta blockers (eg, nadolol) or chronic anemia due to recurrent bleeding can result in increased fatigue and dyspnea, this does not explain the patient&#39;s pulmonary examination findings.&nbsp; Moreover, variceal bleeding is usually large volume and more clinically evident (eg, hematemesis, positive stool guaiac).</p><p><strong>Educational objective:</strong><br>Hepatic hydrothorax generally results in transudative pleural effusions and is thought to occur due to small defects in the diaphragm.&nbsp; Diagnosis involves documentation of the effusion and testing to exclude other causes.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 2874,
            "topic": "Cirrhosis",
            "titleId": 2874,
            "title": "Cirrhosis",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "3",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Alcohol-induced cardiac dysfunction",
                    "choiceNumber": 1,
                    "correctTaken": 794,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Decreased diaphragmatic excursion",
                    "choiceNumber": 2,
                    "correctTaken": 2867,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fluid passage through diaphragmatic defects",
                    "choiceNumber": 3,
                    "correctTaken": 6683,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intrapulmonary vascular dilations",
                    "choiceNumber": 4,
                    "correctTaken": 2615,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Medication adverse effects",
                    "choiceNumber": 5,
                    "correctTaken": 552,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Recurrent variceal bleeding",
                    "choiceNumber": 6,
                    "correctTaken": 439,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "865,1012,true,-1,1*1014,1328,true,-1,1*1752,1998,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27468192",
                    "mediaDataId": 0,
                    "title": "Pulmonary complications of hepatic diseases.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27468192",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 128,
            "othersAvgTimeSpent": 96,
            "notes": null,
            "peopleTaken": 13950,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 48,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 558,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 17,
            "questionId": 15177,
            "questionIndex": 16601,
            "questionText": "<p>A 38-year-old woman, gravida 2 para 1, at 28 weeks gestation comes to the office for a routine prenatal visit.&nbsp; The patient has had no abdominal pain, vaginal bleeding, or leakage of fluid.&nbsp; She reports active fetal movement.&nbsp; The patient has been on antiretroviral therapy since being diagnosed with HIV 3 years ago, and her last viral load was undetectable.&nbsp; She had negative syphilis and hepatitis C screening at her initial prenatal visit.&nbsp; Blood pressure is 122/74 mm Hg, and pulse is 86/min.&nbsp; The abdomen is nontender, and fundal height is 28 cm.&nbsp; Fetal heart tones are 140/min.&nbsp; The rest of the examination is normal.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td style=\"vertical-align:middle;\">10 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td style=\"vertical-align:middle;\">180,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td style=\"vertical-align:middle;\">4,100/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" height=\"15\" style=\"vertical-align:middle; \"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Liver function studies</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Alkaline phosphatase</td><td style=\"vertical-align:middle;\">220 U/L (normal: 38-229 in 3rd trimester)</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Aspartate aminotransferase (SGOT)</td><td style=\"vertical-align:middle;\">300 U/L</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Alanine aminotransferase (SGPT)</td><td style=\"vertical-align:middle;\">254 U/L</td></tr></tbody></table><p>Ultrasound of the right upper quadrant shows no stones or dilation of the common bile duct.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>The differential for abnormal liver enzymes in pregnant patients is broad and includes diseases specific to pregnancy (eg, preeclampsia, acute fatty liver of pregnancy) and those that affect the general population (eg, viral hepatitis, autoimmune hepatitis).&nbsp; This patient has a <strong>hepatocellular pattern</strong> of liver injury (ie, elevated transaminases, normal alkaline phosphatase).&nbsp; In association with the normal vital signs and otherwise normal laboratory values, this presentation is most concerning for <strong>viral hepatitis</strong>, likely hepatitis C.</p><p>Viral hepatitis should remain on the differential for any patient with hepatocellular liver injury, even in those with negative screening tests at their initial prenatal visit because the disease can be contracted at any time and antibody testing may not detect those with very recent exposure.&nbsp; Patients with a history of other blood-borne or sexually transmitted disease (eg, HIV) may be at elevated risk.&nbsp; Most patients are <strong>asymptomatic</strong>, although acute disease can cause pain in the right upper quadrant, nausea, and jaundice.&nbsp; Acute hepatitis often causes markedly elevated aminotransferases (&gt;10-20&times; the upper limit of normal); however, most patients develop <strong>chronic hepatitis C</strong> in the following weeks to months and have less significant aminotransferase elevations.&nbsp; A <strong>viral hepatitis panel</strong> confirms the diagnosis.</p><p><strong>(Choice A)</strong>&nbsp; A 24-hour urine protein collection evaluates for preeclampsia, which can occur in the third trimester and cause elevated aminotransferases.&nbsp; However, this patient does not have hypertension, making this diagnosis unlikely.</p><p><strong>(Choices B and D)</strong>&nbsp; Antinuclear antibody is elevated in autoimmune hepatitis, whereas serum ceruloplasmin is used to evaluate for Wilson disease.&nbsp; Although both diseases can also cause a hepatocellular pattern of injury, they are much less common than viral hepatitis.&nbsp; Furthermore, Wilson disease typically causes extrahepatic manifestations (eg, Kayser-Fleischer rings, neuropsychiatric symptoms).&nbsp; However, an expanded workup (including testing for these diseases) can be considered if the viral hepatitis panel is negative.</p><p><strong>(Choice C)</strong>&nbsp; Immediate delivery is a management option for acute fatty liver of pregnancy, which can present in the third trimester with elevated aminotransferases.&nbsp; However, patients typically are symptomatic (eg, nausea, malaise, right upper quadrant pain) and have additional laboratory abnormalities, including leukocytosis and thrombocytopenia, making this diagnosis unlikely.</p><p><strong>Educational objective:</strong><br>Viral hepatitis should be considered in pregnant patients with a hepatocellular pattern of liver injury (eg, elevated aminotransferases), even in those with negative screening tests at initial prenatal visits.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 7141,
            "topic": "Hepatitis c",
            "titleId": 7141,
            "title": "Hepatitis c",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "5",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "24-hour urine protein collection",
                    "choiceNumber": 1,
                    "correctTaken": 3752,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Antinuclear antibody testing",
                    "choiceNumber": 2,
                    "correctTaken": 1730,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Immediate delivery",
                    "choiceNumber": 3,
                    "correctTaken": 1171,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum ceruloplasmin",
                    "choiceNumber": 4,
                    "correctTaken": 1158,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Viral hepatitis serology",
                    "choiceNumber": 5,
                    "correctTaken": 12933,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "30,289,true,-1,1*408,568,true,-1,1*569,585,true,-1,1*866,976,true,-1,1*1201,1389,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25233195",
                    "mediaDataId": 0,
                    "title": "Hepatitis B and C in pregnancy: a review and recommendations for care.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25233195",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30364573",
                    "mediaDataId": 0,
                    "title": "Sexually acquired acute hepatitis C infection diagnosed during pregnancy: a case report of successful postpartum treatment.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30364573",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28782502",
                    "mediaDataId": 0,
                    "title": "Hepatitis C in pregnancy: screening, treatment, and management.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28782502",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 211,
            "othersAvgTimeSpent": 84,
            "notes": null,
            "peopleTaken": 20744,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 62,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 706,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 18,
            "questionId": 4278,
            "questionIndex": 4278,
            "questionText": "<p>A 50-year-old man is admitted to the hospital with worsening jaundice, anorexia, general malaise, and right upper quadrant abdominal pain over the past 3 days.&nbsp; The patient&#39;s other medical problems include major depression with an attempted suicide 30 years ago.&nbsp; His temperature is 38.3 C (101 F), blood pressure is 130/86 mm Hg, pulse is 86/min, and respirations are 16/min.&nbsp; Cardiopulmonary examination is unremarkable.&nbsp; Scleral icterus and tender hepatomegaly are present.&nbsp; Laboratory results are as follows:</p><blockquote><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"325\"><tbody><tr><td colspan=\"2\">Complete blood count</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td>12 g/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Mean corpuscular volume</td><td>102 &micro;m<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Platelets</td><td>120,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td>13,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" height=\"15\"></td></tr><tr><td colspan=\"2\">Serum chemistry</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Urea nitrogen</td><td>20 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Creatinine</td><td>1.2 mg/dL</td></tr><tr><td colspan=\"2\" height=\"15\"></td></tr><tr><td colspan=\"2\">Liver function studies</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Albumin</td><td>3.4 g/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Total bilirubin</td><td>5.3 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Direct bilirubin</td><td>3.7 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Alkaline phosphatase</td><td>105 U/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Aspartate aminotransferase</td><td>212 U/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Alanine aminotransferase</td><td>99 U/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Amylase</td><td>91 U/L</td></tr><tr><td colspan=\"2\" height=\"15\"></td></tr><tr><td colspan=\"2\">Coagulation studies</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;INR</td><td>1.2 (0.8-1.1)</td></tr></tbody></table></blockquote><p>Which of the following would be the most helpful in establishing a diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><div id=\"div_t80073\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Clinical features of alcoholic hepatitis</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical presentation</strong></p></td><td><ul><li>Jaundice, anorexia, fever</li><li>Right upper quadrant &amp;/or epigastric pain</li><li>Abdominal distension due to ascites</li><li>Proximal muscle weakness from muscle wasting if malnourished</li><li>Possible hepatic encephalopathy</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory &amp; imaging studies</strong></p></td><td><ul><li>Elevated AST &amp; ALT, usually &lt;300 U/L</li><li>AST/ALT ratio &ge;2</li><li>Elevated GGT<strong>,</strong> bilirubin &amp;/or INR</li><li>Leukocytosis, predominantly neutrophils</li><li>Decreased albumin if malnourished</li><li>Abdominal imaging may show fatty liver</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>ALT</strong> = alanine aminotransferase; <strong>AST</strong> = aspartate aminotransferase; <strong>GGT</strong> = gamma-glutamyltransferase<strong>.</strong></p></td></tr></tbody></table></div></p><p><strong>Alcoholic hepatitis</strong> (AH) best explains this patient&#39;s presentation with fever, <strong>jaundice</strong>, anorexia, <strong>tender hepatomegaly</strong>, mild (&lt;300 U/L) elevation in aminotransferases (aspartate aminotransferase [AST] and alanine aminotransferase [ALT]) with an <strong>AST:ALT ratio &#8805;2:1</strong>, macrocytic anemia (mean corpuscular volume [MCV] &gt;100/&micro;m<font size=\"2\"><sup>3</sup></font>), bilirubin elevation, thrombocytopenia, and mild elevation in the International Normalized Ratio.&nbsp; Alcohol use should be confirmed and quantified by first obtaining the patient&#39;s social history and discussing substance use.&nbsp; Patients with AH commonly have a history of chronic, <strong>heavy alcohol use</strong> (&gt;7 drinks/day) and sometimes develop AH symptoms after an acute increase in consumption.</p><p>Diagnosis is clinical and often does not require further studies in patients with consistent history and laboratory results.&nbsp; Patients with risk factors for diseases such as acute viral hepatitis require further investigation.&nbsp; Radiographic imaging may reveal fatty liver disease, cirrhosis, or ascites.&nbsp; Treatment involves abstinence, supportive care (eg, hydration and nutrition support), and acid suppression.&nbsp; Liver biopsy can be helpful if there is diagnostic uncertainty.</p><p><strong>(Choice A)</strong>&nbsp; Family history can be helpful in identifying causes of inherited liver disease (eg, Wilson disease, hemochromatosis); however, an AST:ALT ratio &#8805;2:1 in the setting of acute hepatitis (tender hepatomegaly, fever) is highly suggestive of AH.&nbsp; In addition, this patient&#39;s age makes inherited disease less likely.</p><p><strong>(Choice B)</strong>&nbsp; Methotrexate could cause elevated MCV, bone marrow suppression (anemia, thrombocytopenia), and liver function test abnormalities; however, an AST:ALT ratio &#8805;2:1 makes AH more likely.</p><p><strong>(Choice C)</strong>&nbsp; Cholangitis can cause fever, abdominal pain, and jaundice (Charcot&#39;s triad) and could be evaluated with a right upper quadrant ultrasound.&nbsp; However, cholangitis would typically cause a more severe presentation (eg, sepsis) with a marked elevation in the alkaline phosphatase level; in addition, an AST:ALT ratio &#8805;2:1 with tender hepatomegaly and an elevated MCV are atypical for cholangitis and more suggestive of heavy alcohol use with AH.</p><p><strong>(Choices D and F)</strong>&nbsp; Acetaminophen intoxication and travel-associated diseases (eg, viral hepatitis, malaria, leptospirosis) may present similarly; however, these conditions do not explain the macrocytic anemia and AST:ALT ratio <u>&gt;</u>2:1.&nbsp; In addition, aminotransferase levels are typically &gt;1,000 U/L in acetaminophen intoxication and viral hepatitis.</p><p><strong>Educational objective:</strong><br>Alcoholic hepatitis (AH) is most commonly seen in patients with a history of chronic heavy alcohol use.&nbsp; AH is characterized by fever, jaundice, anorexia, and tender hepatomegaly with laboratory results showing an aspartate aminotransferase to alanine aminotransferase ratio of &#8805;2:1.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 21065,
            "topic": "Alcoholic liver disease",
            "titleId": 21065,
            "title": "Alcoholic liver disease",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Family history",
                    "choiceNumber": 1,
                    "correctTaken": 321,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Medication history",
                    "choiceNumber": 2,
                    "correctTaken": 1275,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Right upper quadrant ultrasound",
                    "choiceNumber": 3,
                    "correctTaken": 6392,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum acetaminophen level",
                    "choiceNumber": 4,
                    "correctTaken": 1727,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Substance use disorder history",
                    "choiceNumber": 5,
                    "correctTaken": 20043,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Travel history to a developing country",
                    "choiceNumber": 6,
                    "correctTaken": 1401,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "198,258,true,-1,1*382,387,true,-1,1*407,446,true,-1,1*481,516,true,-1,1*1221,1256,true,-1,1*1725,1741,true,-1,1*2142,2270,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25955457",
                    "mediaDataId": 0,
                    "title": "Alcoholic hepatitis: Challenges in diagnosis and management.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25955457",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26356792",
                    "mediaDataId": 0,
                    "title": "Diagnosis and management of alcoholic liver disease.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26356792",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 105,
            "othersAvgTimeSpent": 80,
            "notes": null,
            "peopleTaken": 31159,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 64,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 193,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 19,
            "questionId": 4626,
            "questionIndex": 4626,
            "questionText": "<p>A 43-year-old woman comes to the office due to elevated aminotransferase levels, which were identified during routine blood work.&nbsp; She feels well and reports no symptoms.&nbsp; She has no known medical conditions, and her family history is unremarkable.&nbsp; She used heroin 10 years ago but completed rehabilitation and has not used it since.&nbsp; She does not use tobacco or alcohol.&nbsp; Temperature is 37.5 C (99.5 F), blood pressure is 120/80 mm Hg, and pulse is 87/min.&nbsp; BMI is 24.5 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; There is no scleral icterus or asterixis.&nbsp; Skin and cardiopulmonary examinations are unremarkable.&nbsp; The abdomen is soft and nontender; there is no ascites.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Hematocrit</td><td style=\"vertical-align:middle;\">38%</td></tr><tr><td style=\"vertical-align:middle;\">Platelets</td><td style=\"vertical-align:middle;\">145,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">Creatinine</td><td style=\"vertical-align:middle;\">0.8 mg/dL</td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Liver function studies</td></tr><tr><td style=\"padding-left: 2em; vertical-align:middle;\">Albumin</td><td style=\"vertical-align:middle;\">2.8 g/dL</td></tr><tr><td style=\"padding-left: 2em; vertical-align:middle;\">Total bilirubin</td><td style=\"vertical-align:middle;\">1.2 mg/dL</td></tr><tr><td style=\"padding-left: 2em; vertical-align:middle;\">Alkaline phosphatase</td><td style=\"vertical-align:middle;\">120 U/L</td></tr><tr><td style=\"padding-left: 2em; vertical-align:middle;\">Aspartate aminotransferase (SGOT)</td><td style=\"vertical-align:middle;\">120 U/L</td></tr><tr><td style=\"padding-left: 2em; vertical-align:middle;\">Alanine aminotransferase (SGPT)</td><td style=\"vertical-align:middle;\">134 U/L</td></tr><tr><td style=\"vertical-align:middle;\">INR</td><td style=\"vertical-align:middle;\">1.7</td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Hepatitis panel</td></tr><tr><td style=\"padding-left: 2em; vertical-align:middle;\">Hepatitis A virus IgG antibody</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"padding-left: 2em; vertical-align:middle;\">Hepatitis A virus IgM antibody</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"padding-left: 2em; vertical-align:middle;\">Hepatitis B surface IgG antibody</td><td style=\"vertical-align:middle;\">positive</td></tr><tr><td style=\"padding-left: 2em; vertical-align:middle;\">Hepatitis B surface antigen</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"padding-left: 2em; vertical-align:middle;\">Hepatitis C virus antibody</td><td style=\"vertical-align:middle;\">positive</td></tr><tr><td style=\"padding-left: 2em; vertical-align:middle;\">Hepatitis C virus RNA</td><td style=\"vertical-align:middle;\">1,978,677 IU/mL</td></tr></tbody></table><p>Abdominal ultrasonography reveals a nodular, shrunken liver without evidence of ascites.&nbsp; Upper endoscopy is negative for esophageal or gastric varices.&nbsp; In addition to providing antiviral therapy to treat this patient&#39;s hepatitis C infection, which of the following would be recommended at this time?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T72306\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Overview of cirrhosis management</strong></p></td></tr><tr><td><p align=\"center\"><strong>Treat underlying<br>liver disease</strong></p></td><td><ul><li>HCV, HBV: antiviral therapy</li><li>NASH: weight loss</li></ul></td></tr><tr><td><p align=\"center\"><strong>Provide<br>preventive care</strong></p></td><td><ul><li>Avoid alcohol &amp; hepatotoxic medications</li><li>Vaccinate for HAV &amp; HBV (unless already immune)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Manage<br>complications</strong></p></td><td><ul><li>Screen for esophageal varices (endoscopy)</li><li>Screen for HCC: ultrasound &plusmn; serum AFP every 6-12 months</li><li>Frequent clinical assessment for ascites and encephalopathy (prophylactic treatment not recommended)</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>AFP</strong> = alpha fetoprotein; <strong>HAV</strong> = hepatitis A virus; <strong>HBV</strong> = hepatitis B virus; <strong>HCC</strong> = hepatocellular carcinoma; <strong>HCV</strong> = hepatitis C virus; <strong>NASH</strong> = nonalcoholic steatohepatitis.</p></td></tr></tbody></table></div><p>This patient has <strong>hepatitis C virus (HCV) cirrhosis</strong> confirmed by positive HCV antibodies, elevated HCV RNA levels, and a <strong>nodular, shrunken liver</strong> on ultrasound.&nbsp; Although <a href=\"45218\">chronic HCV infection</a> is often asymptomatic and may cause only mild elevations in aminotransferases, some infected individuals (~20%) develop cirrhosis.&nbsp; Laboratory findings suggestive of cirrhosis include <strong>thrombocytopenia</strong>, <strong>hypoalbuminemia</strong>, and <strong>coagulopathy</strong> (eg, elevated PT/INR).&nbsp; Liver biopsy showing extensive fibrosis and regenerative nodules can confirm the diagnosis if necessary.</p><p>A priority of cirrhosis management is to protect patients from further hepatic insult.&nbsp; Patients should be <strong>vaccinated against both hepatitis A virus (HAV) and hepatitis B virus (HBV)</strong> if there is no evidence of immunity (eg, positive HAV IgG, positive HBV surface antibody).&nbsp; Acute HAV or HBV infection in unvaccinated/nonimmune patients with cirrhosis can cause severe acute or chronic liver failure.&nbsp; This patient has evidence of immunity to HBV&nbsp;but not HAV and therefore should be vaccinated against HAV.</p><p><strong>(Choices A and E)</strong>&nbsp; This patient does not require vaccination against or treatment for HBV because she does not have active infection (eg, negative HBV surface antigen) and is already immune (eg, positive HBV surface IgG antibody).</p><p><strong>(Choice B)</strong>&nbsp; Patients with cirrhosis should be frequently assessed for features of hepatic encephalopathy (eg, abnormal mental status, sleep disturbance, asterixis), but asymptomatic patients do not require treatment (eg, lactulose, rifaximin).</p><p><strong>(Choice C)</strong>&nbsp; Cirrhosis predisposes to ascites, which is treated with diuretics (eg, spironolactone, furosemide), but prophylactic therapy is not recommended for patients without ascites.</p><p><strong>(Choice F)</strong>&nbsp; This patient with cirrhosis requires vaccination against HAV.</p><p><strong>Educational objective:</strong><br>Patients with cirrhosis from any cause, including chronic hepatitis C virus, should be vaccinated against both hepatitis A virus (HAV) and hepatitis B (HBV) virus unless they have serologic evidence of immunity.&nbsp; Acute HAV or HBV infection in unvaccinated/nonimmune patients with cirrhosis can cause severe acute or chronic liver failure.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 7141,
            "topic": "Hepatitis c",
            "titleId": 7141,
            "title": "Hepatitis c",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Antiviral therapy for hepatitis B",
                    "choiceNumber": 1,
                    "correctTaken": 258,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Daily lactulose",
                    "choiceNumber": 2,
                    "correctTaken": 593,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Daily spironolactone",
                    "choiceNumber": 3,
                    "correctTaken": 374,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hepatitis A vaccination",
                    "choiceNumber": 4,
                    "correctTaken": 9338,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hepatitis B vaccination",
                    "choiceNumber": 5,
                    "correctTaken": 500,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "No additional intervention",
                    "choiceNumber": 6,
                    "correctTaken": 2947,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "204,251,true,-1,1*315,370,true,-1,1*433,472,true,-1,1*801,963,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26131943",
                    "mediaDataId": 0,
                    "title": "Diagnosis and management of hepatitis C.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26131943",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 151,
            "othersAvgTimeSpent": 72,
            "notes": null,
            "peopleTaken": 14010,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 67,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1110,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 20,
            "questionId": 4648,
            "questionIndex": 4648,
            "questionText": "<p>A 75-year-old man is brought to the emergency department from home after being found unresponsive by his son.&nbsp; His medical history is significant for coronary artery disease with coronary stenting 2 years ago, diabetes mellitus, hypertension, and stroke.&nbsp; He was hospitalized 2 months ago with pneumonia and upper gastrointestinal bleeding, during which time he received intravenous antibiotics and a transfusion of 4 units of packed red blood cells. &nbsp;In the emergency department today, temperature is 39.1 C (102.4 F), blood pressure is 70/40 mm Hg, pulse is 120/min, respiratory rate is 32/min, and oxygen saturation is 79% on room air.&nbsp; Laboratory results are notable for leukocytosis but are otherwise unremarkable.&nbsp; Chest x-ray reveals a new right upper lobe infiltrate.&nbsp; He is treated with normal saline, antibiotics, vasopressors, and mechanical ventilation.&nbsp; The next day, laboratory analyses reveal the following:</p><blockquote><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"350\"><tbody><tr><td width=\"60%\">Hemoglobin</td><td width=\"40%\">9.5 mg/dL</td></tr><tr><td width=\"60%\">Leukocytes</td><td width=\"40%\">15,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td width=\"60%\">Platelet</td><td width=\"40%\">120,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td width=\"60%\">Sodium</td><td width=\"40%\">137 mEq/L</td></tr><tr><td width=\"60%\">Potassium</td><td width=\"40%\">4.1 mEq/L</td></tr><tr><td width=\"60%\">Chloride</td><td width=\"40%\">100 mEq/L</td></tr><tr><td width=\"60%\">Bicarbonate</td><td width=\"40%\">19 mEq/L</td></tr><tr><td width=\"60%\">Blood urea nitrogen</td><td width=\"40%\">51 mg/dL</td></tr><tr><td width=\"60%\">Creatinine</td><td width=\"40%\">2.1 mg/dL</td></tr><tr><td width=\"60%\">Bilirubin, total</td><td width=\"40%\">1.2 mg/dL</td></tr><tr><td width=\"60%\">Aspartate aminotransferase</td><td width=\"40%\">3,720 units/L</td></tr><tr><td width=\"60%\">Alanine aminotransferase</td><td width=\"40%\">3,250 units/L</td></tr><tr><td width=\"60%\">Alkaline phosphatase</td><td width=\"40%\">162 mEq/L</td></tr></tbody></table></blockquote><p>Which of the following most likely accounts for the abnormal liver function panel?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient presented with unresponsiveness, likely from septic shock (hypotension requiring vasopressors, respiratory failure requiring mechanical ventilation) in the setting of pneumonia (right upper lobe infiltrate, leukocytosis, fever).&nbsp; One day later, he developed elevations in the aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels.&nbsp; This presentation is most consistent with <strong>ischemic hepatic injury</strong>, or shock liver.</p><p>The hallmark of ischemic hepatopathy is a <strong>rapid and significant increase in the transaminases</strong> with modest accompanying elevations in total bilirubin and alkaline phosphatase.&nbsp; AST and ALT levels peak at 25 to 250 times the upper limit of normal and can reach&nbsp;&gt;10,000 U/L.&nbsp; This reflects <strong>diffuse liver injury</strong> due to <strong>hypotension</strong>; as a result of the liver&#39;s dual blood supply, diffuse injury is more common than focal infarction.&nbsp; In patients who survive the <strong>underlying cause</strong> of their hypotension (eg, septic shock, heart failure), liver enzymes typically return to normal within 1-2 weeks.</p><p><strong>(Choice A)</strong>&nbsp; Acute viral hepatitis can lead to&nbsp;large AST and ALT elevations but is typically accompanied by significant hyperbilirubinemia, nausea, and vomiting.&nbsp; Although this patient recently received blood transfusions, donor blood screening has virtually eliminated the risk of blood transfusion&ndash;associated hepatitis C infection.</p><p><strong>(Choice B)</strong>&nbsp; Alcoholic liver disease typically causes less dramatic increases in the transaminases compared to those seen in this patient.&nbsp; The AST/ALT ratio is usually ~2, and the AST is rarely &gt;300 units/L.</p><p><strong>(Choice C)</strong>&nbsp; Granulomatous disorders (eg, tuberculosis, sarcoidosis) rarely cause massive transaminase elevations. &nbsp;Chronic hepatic damage is occasionally associated.</p><p><strong>(Choice E)</strong>&nbsp; Acalculous cholecystitis is a common complication of critical illness that arises due to gallbladder stasis. &nbsp;Patients have symptoms of biliary obstruction.&nbsp; Elevations of the alkaline phosphatase and total bilirubin levels are more significant than those of the transaminase levels.</p><p><strong>(Choice F)</strong>&nbsp; Iron overload may cause chronic hepatic dysfunction with low-grade elevations in the AST and ALT. &nbsp;Transfusion of 4 units of packed red blood cells&nbsp;would be unlikely to cause iron overload.</p><p><strong>(Choice G)</strong>&nbsp; Autoimmune hepatitis may cause large increases in the AST and ALT.&nbsp; However, young women are more commonly affected, and the associated serum bilirubin increases are typically more dramatic.</p><p><strong>Educational objective:</strong><br>Ischemic hepatic injury occurs in the setting of hypotension and manifests as acute, massive increases in the transaminases with milder associated increases in the total bilirubin and alkaline phosphatase. &nbsp;In patients who survive the inciting condition (eg, hypotension), liver enzymes typically return to normal within a few weeks.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 12508,
            "topic": "Ischemic hepatitis",
            "titleId": 12508,
            "title": "Ischemic hepatitis",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acute viral hepatitis",
                    "choiceNumber": 1,
                    "correctTaken": 3031,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Alcoholic liver disease",
                    "choiceNumber": 2,
                    "correctTaken": 470,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Granulomatous liver disease",
                    "choiceNumber": 3,
                    "correctTaken": 669,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ischemic hepatic injury",
                    "choiceNumber": 4,
                    "correctTaken": 10832,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Acalculous cholecystitis",
                    "choiceNumber": 5,
                    "correctTaken": 286,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Iron overload",
                    "choiceNumber": 6,
                    "correctTaken": 533,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Autoimmune hepatitis",
                    "choiceNumber": 7,
                    "correctTaken": 615,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "465,478,true,-1,1*479,652,true,-1,1*807,906,true,-1,1*1941,2002,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "624",
                    "mediaDataId": 0,
                    "title": "Evaluation of abnormal liver function tests (LFTs)",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 225,
            "othersAvgTimeSpent": 91,
            "notes": null,
            "peopleTaken": 16436,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 66,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 780,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 21,
            "questionId": 2937,
            "questionIndex": 2937,
            "questionText": "<p>A 36-year-old man comes to the office.</p><p><u><strong>History</strong></u><br>Reason for visit/chief concern:&nbsp; &#x22;I&#39;m just here for a check-up.&#x22;<br>Symptoms:&nbsp; &#x22;I feel fine right now.&#x22;<br>Past medical and surgical history:&nbsp; occasional headaches, cellulitis 10 years ago, clavicle fracture in high school<br>Medications:&nbsp; &#x22;I take ibuprofen for tension headache if I need to.&#x22;<br>Family history:&nbsp; hypertension in father, knee osteoarthritis in mother<br>Social history:&nbsp; tobacco use, &#x22;no&#x22;; alcohol use, &#x22;socially&#x22;; recreational drug use, &#x22;no&#x22;; works as a medical assistant</p><p><u><strong>Physical examination</strong></u><br>Vital signs:&nbsp; blood pressure 121/68 mm Hg, pulse 66/min; BMI 29.1 kg/m<font size=\"2\"><sup>2</sup></font><br>Pulmonary:&nbsp; clear lungs<br>Cardiac:&nbsp; normal heart sounds, no murmurs<br>Abdominal:&nbsp; soft and nontender, liver and spleen cannot be palpated<br>Neurologic:&nbsp; no abnormalities</p><p><u><strong>Laboratory results</strong></u></p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"vertical-align:middle; padding-left:2em;\">Hemoglobin</td><td style=\"vertical-align:middle;\">13.8 g/dL</td></tr><tr><td style=\"vertical-align:middle; padding-left:2em;\">Platelets</td><td style=\"vertical-align:middle;\">290,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle; padding-left:2em;\">Leukocytes</td><td style=\"vertical-align:middle;\">5,500/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Serum chemistry</td></tr><tr><td style=\"vertical-align:middle; padding-left:2em;\">Sodium</td><td style=\"vertical-align:middle;\">142 mEq/L</td></tr><tr><td style=\"vertical-align:middle; padding-left:2em;\">Potassium</td><td style=\"vertical-align:middle;\">3.9 mEq/L</td></tr><tr><td style=\"vertical-align:middle; padding-left:2em;\">Creatinine</td><td style=\"vertical-align:middle;\">0.9 mg/dL</td></tr><tr><td style=\"vertical-align:middle; padding-left:2em;\">Glucose</td><td style=\"vertical-align:middle;\">92 mg/dL</td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Liver function studies</td></tr><tr><td style=\"vertical-align:middle; padding-left:2em;\">Albumin</td><td style=\"vertical-align:middle;\">4.2 g/dL</td></tr><tr><td style=\"vertical-align:middle; padding-left:2em;\">Total bilirubin</td><td style=\"vertical-align:middle;\">0.9 mg/dL</td></tr><tr><td style=\"vertical-align:middle; padding-left:2em;\">Alkaline phosphatase</td><td style=\"vertical-align:middle;\">60 U/L</td></tr><tr><td style=\"vertical-align:middle; padding-left:2em;\">Aspartate aminotransferase (SGOT)</td><td style=\"vertical-align:middle;\">188 U/L</td></tr><tr><td style=\"vertical-align:middle; padding-left:2em;\">Alanine aminotransferase (SGPT)</td><td style=\"vertical-align:middle;\">98 U/L</td></tr></tbody></table><p>Which of the following is the best next step in management of this patient&#39;s laboratory abnormalities?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t91176\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Diagnostic approach to abnormal liver function test results</strong></p></td></tr><tr><td><p align=\"center\"><strong>History</strong></p></td><td><ul><li>Detailed alcohol intake assessment (frequency, quantity)</li><li>Hepatitis risk factor assessment (eg, sexual history)</li><li>Medication review (eg, acetaminophen, supplement use)</li><li>Family history (eg, autoimmune disease)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Physical examination</strong></p></td><td><ul><li>Assess for:<ul style=\"list-style-type:circle;\"><li>Stigmata of cirrhosis (eg, palmar erythema, spider angiomas)</li><li>Signs of malignancy (eg, lymph node enlargement)</li><li>Volume overload (eg, elevated jugular venous pressure)</li><li>Visceral obesity (eg, truncal obesity)</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnostic testing</strong></p></td><td><ul><li>Selective laboratory testing based on risk factors</li><li>Hepatocellular pattern: viral serologies, antinuclear antibody, iron studies</li><li>Cholestatic pattern: &gamma;-glutamyltransferase, pancreatic enzymes, liver ultrasonography</li></ul></td></tr></tbody></table></div><p>This <strong>asymptomatic</strong> patient has isolated elevation of hepatic aminotransferases (ie, hepatocellular pattern), raising concern for <strong>hepatocellular injury</strong>.&nbsp; The differential diagnosis of this type of liver injury is broad.&nbsp; Common conditions include alcoholic, drug-induced, or viral hepatitis; hemochromatosis; and nonalcoholic fatty liver disease (NAFLD).&nbsp; Assessing for diagnostic clues obtained through <strong>thorough history</strong>, physical examination, and basic laboratory testing can narrow the differential diagnosis and elucidate the most appropriate next steps in work-up.</p><p>The history should assess for risk factors for viral (eg, drug use) or autoimmune hepatitis.&nbsp; In addition, the social history should include <strong>detailed information on alcohol intake</strong>: excessive alcohol consumption (&gt;1 drink/day for women, &gt;2 drinks/day for men, binge drinking) can be associated with marked elevations in aminotransferases,&nbsp;typically <strong>AST &gt; ALT</strong>&nbsp;with a <strong>ratio near 2:1</strong>, as seen in this patient.&nbsp; This patient has said that he consumes alcohol &#x22;socially,&#x22; which is somewhat vague as it could reflect a range of drinking patterns, including some that may be excessive&nbsp;(eg, multiple daily&nbsp;drinks&nbsp;with friends, regular binge drinking on weekends).&nbsp; Particularly given the AST to ALT ratio of ~2:1,&nbsp;more detail is needed (ie, frequency, amount, duration) to determine diagnostic probability of alcoholic hepatitis.</p><p><strong>(Choices A and E)</strong>&nbsp; NAFLD is the most common liver disease in patients with overweight or obesity; it can be diagnosed with abdominal ultrasonography and is managed with weight loss.&nbsp; However, NAFLD is a diagnosis of exclusion; other causes of liver disease such as heavy alcohol use should be ruled out first.</p><p><strong>(Choice B)</strong>&nbsp; Viral hepatitis is a common cause of aminotransferase abnormalities, and viral serologies are commonly checked as part of subsequent laboratory evaluation.&nbsp; However, the AST to ALT ratio of ~2:1 seen in this patient is highly suggestive of alcoholic hepatitis.&nbsp; Therefore, alcohol intake should be assessed first; cessation of excessive alcohol intake is required even if the patient ultimately is found to have a viral etiology for his liver disease.</p><p><strong>(Choice D)</strong>&nbsp; The most common adverse effects of ibuprofen use are nephrotoxicity and gastrointestinal mucosal injury; liver injury is much less common.&nbsp; In this asymptomatic patient with normal kidney function, ibuprofen-induced hepatotoxicity is unlikely.</p><p><strong>Educational objective:</strong><br>The evaluation of asymptomatic elevation of aminotransferases begins with a detailed history of alcohol intake, viral hepatitis risk factors (eg, high-risk sexual practices), medication use, and family history.&nbsp; Excessive alcohol consumption can be associated with marked elevations in aminotransferases, typically AST &gt; ALT with a ratio near 2:1.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 23688,
            "topic": "Abnormal lfts",
            "titleId": 23688,
            "title": "Abnormal lfts",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "3",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Advise weight loss and repeat testing in 3 months",
                    "choiceNumber": 1,
                    "correctTaken": 853,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Conduct viral serology testing",
                    "choiceNumber": 2,
                    "correctTaken": 866,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain detailed history about alcohol intake",
                    "choiceNumber": 3,
                    "correctTaken": 13644,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain detailed history about ibuprofen use",
                    "choiceNumber": 4,
                    "correctTaken": 661,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Perform abdominal ultrasonography",
                    "choiceNumber": 5,
                    "correctTaken": 557,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "263,302,true,-1,1*446,539,true,-1,1*687,772,true,-1,1*1520,1614,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "624",
                    "mediaDataId": 0,
                    "title": "Evaluation of abnormal liver function tests (LFTs)",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29431403",
                    "mediaDataId": 0,
                    "title": "Mildly elevated liver transaminase levels: causes and evaluation",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29431403",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 148,
            "othersAvgTimeSpent": 57,
            "notes": null,
            "peopleTaken": 16581,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 82,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1197,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 22,
            "questionId": 14661,
            "questionIndex": 16076,
            "questionText": "<p>A 50-year-old man comes to the office due to 2 months of progressive generalized weakness, anorexia, and abdominal distension.&nbsp; He has also had lower extremity swelling bilaterally.&nbsp; The patient has a history of alcohol use disorder and liver cirrhosis, which was diagnosed 5 years ago.&nbsp; Ultrasonography of the right upper quadrant, performed 18 months ago, revealed surface nodularity and increased liver echogenicity but no free fluid.&nbsp; The patient has no other chronic medical conditions and takes no medications.&nbsp; Temperature is 37.3 C (99.1 F), blood pressure is 103/76 mm Hg, pulse is 82/min, and respirations are 14/min.&nbsp; Pulse oximetry shows 96% on room air.&nbsp; On physical examination, the abdomen is distended, with shifting dullness to percussion, but nontender.&nbsp; There is bilateral lower extremity 1+ pitting edema.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\">Complete blood count</td></tr><tr><td style=\"padding-left: 2em;\">Hemoglobin</td><td>11.2 g/dL</td></tr><tr><td style=\"padding-left: 2em;\">Platelets</td><td>105,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"padding-left: 2em;\">Leukocytes</td><td>6,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td colspan=\"2\"></td></tr><tr><td colspan=\"2\">Serum chemistry</td></tr><tr><td style=\"padding-left: 2em;\">Blood urea nitrogen</td><td>15 mg/dL</td></tr><tr><td style=\"padding-left: 2em;\">Creatinine</td><td>0.6 mg/dL</td></tr><tr><td colspan=\"2\"></td></tr><tr><td colspan=\"2\">Liver function studies</td></tr><tr><td style=\"padding-left: 2em;\">Albumin</td><td>3.1 g/dL</td></tr><tr><td style=\"padding-left: 2em;\">Total bilirubin</td><td>2.1 mg/dL</td></tr><tr><td style=\"padding-left: 2em;\">Alkaline phosphatase</td><td>330 U/L</td></tr><tr><td style=\"padding-left: 2em;\">Aspartate aminotransferase (SGOT)</td><td>95 U/L</td></tr><tr><td style=\"padding-left: 2em;\">Alanine aminotransferase (SGPT)</td><td>89 U/L</td></tr></tbody></table><p>Serology is negative for viral hepatitis.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient with alcohol-induced cirrhosis now has new <strong>ascites</strong>, manifesting with abdominal swelling, abdominal distension, and <strong>shifting dullness</strong> on percussion.&nbsp; Although chronic ascites often occurs with progressive cirrhosis, <strong>new-onset ascites</strong> raises concern for <strong>hepatocellular carcinoma</strong> (HCC) or thrombus obstructing the portal or hepatic veins.&nbsp; Therefore, <strong>abdominal ultrasonography</strong> is required to evaluate the abdominal cavity for free fluid, the portal/hepatic vascular system for clots, and the liver for masses.</p><p>Patients with cirrhosis are at extremely high risk for developing HCC.&nbsp; New-onset ascites or any sign of liver decompensation (eg, variceal bleeding) should raise concern for the diagnosis; however, patients with HCC can be asymptomatic.&nbsp; Therefore, patients with cirrhosis should undergo <strong>screening</strong> abdominal ultrasonography <strong>every 6 months</strong>.&nbsp; This patient who had a negative screening ultrasonography 18 months ago may have developed HCC in the interim.</p><p><strong>(Choice B)</strong>&nbsp; Primary biliary cholangitis (PBC), associated with antimitochondrial antibodies, can cause fatigue and elevated alkaline phosphatase and increase the risk for HCC.&nbsp;&nbsp;However, PBC is rare, classically causes pruritus, and occurs almost exclusively in middle-aged women.&nbsp; Abdominal ultrasonography is a more appropriate initial step for assessing liver pathology.</p><p><strong>(Choice C)</strong>&nbsp; Treatment for cirrhosis-associated ascites includes diuresis and salt restriction; however, the cause of new-onset ascites should first be diagnosed with abdominal ultrasonography to assess for secondary causes (eg, portal and hepatic vein thrombosis, HCC) prior to empiric diuretic therapy.</p><p><strong>(Choice D)</strong>&nbsp; Patients with congestive heart failure can develop ascites and lower extremity edema.&nbsp; However, this patient&#39;s history of cirrhosis makes his ascites most likely due to a hepatic cause; therefore, abdominal ultrasonography, not echocardiography, is recommended first.</p><p><strong>(Choice E)</strong>&nbsp; Lactulose is used to treat hepatic encephalopathy, which is associated with confusion and asterixis.&nbsp; This patient is alert and oriented; he has no evidence of encephalopathy.</p><p><strong>Educational objective:</strong><br>New-onset (versus chronic) ascites in patients with cirrhosis is a potential manifestation of hepatocellular carcinoma (HCC) (eg, causing portal or hepatic venous obstruction) and should be investigated with abdominal ultrasonography.&nbsp; In addition, asymptomatic patients with cirrhosis should undergo regular ultrasonography-based screening for HCC every 6 months.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 7162,
            "topic": "Hepatocellular cancer",
            "titleId": 7162,
            "title": "Hepatocellular cancer",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Abdominal ultrasonography",
                    "choiceNumber": 1,
                    "correctTaken": 9923,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Antimitochondrial antibodies",
                    "choiceNumber": 2,
                    "correctTaken": 734,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Diuretic therapy and follow-up in 2 weeks",
                    "choiceNumber": 3,
                    "correctTaken": 2979,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Echocardiography",
                    "choiceNumber": 4,
                    "correctTaken": 628,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lactulose with follow-up in 2 weeks",
                    "choiceNumber": 5,
                    "correctTaken": 847,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "258,378,true,-1,1*431,548,true,-1,1*550,740,true,-1,1*789,889,true,-1,1*1151,1177,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "410",
                    "mediaDataId": 0,
                    "title": "Cirrhosis",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "31439937",
                    "mediaDataId": 0,
                    "title": "A global view of hepatocellular carcinoma: trends, risk, prevention and management.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/31439937",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 183,
            "othersAvgTimeSpent": 91,
            "notes": null,
            "peopleTaken": 15111,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 66,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 904,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 23,
            "questionId": 19598,
            "questionIndex": 21084,
            "questionText": "<p>A 2-day-old girl is being evaluated in the newborn nursery.&nbsp; The patient was born at 38 weeks gestation to a 28-year-old primigravida via spontaneous vaginal delivery.&nbsp; The pregnancy was uneventful.&nbsp; Maternal blood type is B, Rh-D positive, and the patient&#39;s blood type is O, Rh-D positive.&nbsp; Apgar scores were 8 and 9 at 1 and 5 minutes, respectively.&nbsp; The patient is breastfeeding exclusively and has had 3 wet diapers in the last day.&nbsp; She passed meconium yesterday.&nbsp; The mother noticed mild yellowing of the skin after the last feed.&nbsp; Vital signs are normal.&nbsp; The patient is currently asleep.&nbsp; The anterior fontanelle is open, soft, and flat.&nbsp; There is a firm fluid collection in the left parietal scalp, localized within suture lines.&nbsp; The tympanic membranes are normal bilaterally.&nbsp; The oropharynx is clear and moist.&nbsp; Cardiopulmonary examination is unremarkable.&nbsp; The abdomen is soft with normal bowel sounds.&nbsp; The liver is palpable 2 cm below the costal margin.&nbsp; Skin examination shows jaundice, and there is mild scleral icterus.&nbsp; Which of the following is this patient&#39;s greatest risk factor for developing severe hyperbilirubinemia?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T73122\"><table class=\"table-default-style table-header-footer-style\" style=\"width:554px\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Neonatal indirect hyperbilirubinemia</strong></p></td></tr><tr><td><p align=\"center\"><strong>Cause</strong></p></td><td><p align=\"center\"><strong>Examples</strong></p></td></tr><tr><td><p align=\"center\"><strong>&#8593; Bilirubin<br>production</strong></p></td><td><ul><li>Immune-mediated hemolysis (Coombs positive)<ul style=\"list-style-type:circle;\"><li>Rh isoimmunization</li><li>ABO incompatibility</li></ul></li><li>Nonimmune-mediated hemolysis (Coombs negative)<ul style=\"list-style-type:circle;\"><li>RBC membrane defects (eg, spherocytosis)</li><li>RBC enzyme defects (eg, G6PD deficiency)</li></ul></li><li>Cephalohematoma</li><li>Polycythemia</li></ul></td></tr><tr><td><p align=\"center\"><strong>&#8595; Bilirubin<br>clearance</strong></p></td><td><ul><li>Gilbert syndrome</li><li>Crigler-Najjar syndrome</li></ul></td></tr><tr><td><p align=\"center\"><strong>&#8593; Enterohepatic<br>circulation</strong></p></td><td><ul><li>Lactation failure jaundice</li><li>Breastmilk jaundice</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>G6PD</strong> = glucose-6-phophatase dehydrogenase; <strong>RBC</strong> = red blood cell.</p></td></tr></tbody></table></div><p>Nearly all newborns develop varying degrees of jaundice with <a href=\"1741\">indirect hyperbilirubinemia</a> due to physiologically increased bilirubin production, decreased bilirubin clearance, and increased enterohepatic circulation.&nbsp; <strong>Risk factors</strong> for <strong>severe hyperbilirubinemia</strong> include the following:</p><ul><li>Perinatal factors:&nbsp; <strong>prematurity</strong>, exclusive breastfeeding</li><li>Examination findings:&nbsp; <strong>cephalohematoma</strong>, bruising, <strong>jaundice at age &lt;24 hours</strong></li><li>Laboratory findings:&nbsp; <strong>ABO incompatibility</strong>, inherited red blood cell defect (eg, spherocytosis)</li><li>Family history:&nbsp; East Asian ethnicity, sibling who received phototherapy</li></ul><p>In this case, the patient has localized <strong>scalp swelling</strong> that is contained within the suture lines, findings consistent with a <a href=\"725\">cephalohematoma</a>.&nbsp; A cephalohematoma results from birth trauma and typically self-resolves within weeks.&nbsp; However, as the <strong>red blood cells</strong> within the closed space begin to <strong>break down</strong> in the first few days of life, <strong>unconjugated bilirubin</strong> is <strong>resorbed</strong> and can lead to severe hyperbilirubinemia.</p><p>Exclusive breastfeeding is also a potential risk factor for hyperbilirubinemia but typically relates to inadequate milk supply (ie, lactation failure jaundice), leading to weight loss, dehydration, and increased enterohepatic circulation.&nbsp; This patient&#39;s 3 wet diapers on day 2 of life are normal and suggest sufficient hydration and milk supply.</p><p><strong>(Choices A and D)</strong>&nbsp; Jaundice that develops at age &gt;24 hours, as in this case, is often physiologic and is not a risk factor for severe disease.&nbsp; In contrast, the onset of jaundice at age &lt;24 hours is always pathologic and often due to congenital infection or hemolysis (eg, ABO incompatibility).&nbsp; Moreover, ABO incompatibility typically affects newborns with blood type A or B, not type O, who are born to mothers with blood type O due to transplacental transfer of anti-A or anti-B antibodies.</p><p><strong>(Choice B)</strong>&nbsp; Neonatal hepatomegaly (liver edge &gt;3 cm below costal margin) raises concern for a congenital infection or cholestatic condition, both of which increase the risk of hyperbilirubinemia.&nbsp; This patient has a normal abdominal examination for her age.</p><p><strong>(Choice C)</strong>&nbsp; In contrast to a term infant like this patient, preterm infants (gestational age &lt;37 weeks) are at increased risk for hyperbilirubinemia; pathogenesis relates to the relative immaturity of the liver (which results in decreased bilirubin conjugation) as well as decreased enteral feeds (which increase enterohepatic circulation).</p><p><strong>Educational objective:</strong><br>Although all newborns have physiologic indirect hyperbilirubinemia, risk factors for severe hyperbilirubinemia include ABO incompatibility, cephalohematoma, prematurity, and jaundice at age &lt;24 hours.&nbsp; Cephalohematoma can lead to jaundice due to the release of unconjugated bilirubin from excessive red blood cell breakdown.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 24790,
            "topic": "Neonatal jaundice",
            "titleId": 24790,
            "title": "Neonatal jaundice",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "5",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Discrepancy in maternal-infant blood type",
                    "choiceNumber": 1,
                    "correctTaken": 1961,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Enlargement of the liver",
                    "choiceNumber": 2,
                    "correctTaken": 3093,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Gestational age of the infant",
                    "choiceNumber": 3,
                    "correctTaken": 419,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Onset of jaundice after 24 hours of life",
                    "choiceNumber": 4,
                    "correctTaken": 2560,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Presence of scalp swelling",
                    "choiceNumber": 5,
                    "correctTaken": 8694,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "132,147,true,-1,1*218,232,true,-1,1*317,345,true,-1,1*437,483,true,-1,1*765,1132,true,-1,1*1914,2187,true,-1,1*2201,2388,true,-1,1*2399,2460,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29262234",
                    "mediaDataId": 0,
                    "title": "Cephalohematoma.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29262234",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25077393",
                    "mediaDataId": 0,
                    "title": "Evaluation and management of neonatal hyperbilirubinemia.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25077393",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 84,
            "othersAvgTimeSpent": 65,
            "notes": null,
            "peopleTaken": 16727,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 52,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1732,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 24,
            "questionId": 19667,
            "questionIndex": 21154,
            "questionText": "<p>A 22-year-old man comes to the office due to yellow eyes lasting a day.&nbsp; Over the past 3 days, the patient has had fever, fatigue, nasal discharge, and sore throat.&nbsp; He has no chronic medical conditions.&nbsp; His only medication is acetaminophen as needed for current symptoms.&nbsp; The patient drinks 4 or 5 alcoholic beverages a week, and the last drink was 3 days ago.&nbsp; Temperature is 38 C (100.4 F), blood pressure is 120/78 mm Hg, pulse is 80/min, and respirations are 16/min.&nbsp; Examination shows scleral icterus; the oropharynx is erythematous without exudates.&nbsp; There is no pallor or lymphadenopathy.&nbsp; Liver span is 11 cm, and a firm, nontender liver edge is palpable.&nbsp; There is no splenomegaly.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Hemoglobin</td><td style=\"vertical-align:middle;\">13.5 g/dL</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Reticulocytes</td><td style=\"vertical-align:middle;\">1%</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Leukocytes</td><td style=\"vertical-align:middle;\">7,500/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;padding-left:4em\">Neutrophils</td><td style=\"vertical-align:middle;\">50%</td></tr><tr><td style=\"vertical-align:middle;padding-left:4em\">Lymphocytes</td><td style=\"vertical-align:middle;\">40%</td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Liver function studies</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Total bilirubin</td><td style=\"vertical-align:middle;\">3.5 mg/dL</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Direct bilirubin</td><td style=\"vertical-align:middle;\">0.2 mg/dL</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Alkaline phosphatase</td><td style=\"vertical-align:middle;\">78 U/L</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Aspartate aminotransferase (SGOT)</td><td style=\"vertical-align:middle;\">16 U/L</td></tr><tr><td style=\"vertical-align:middle;padding-left:2em\">Alanine aminotransferase (SGPT)</td><td style=\"vertical-align:middle;\">20 U/L</td></tr></tbody></table><p>What is the most likely cause of jaundice in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t69343\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Gilbert syndrome</strong></p></td></tr><tr><td><p align=\"center\"><strong>Epidemiology</strong></p></td><td><ul><li>Most common inherited disorder of bilirubin metabolism</li></ul></td></tr><tr><td><p align=\"center\"><strong>Pathogenesis</strong></p></td><td><ul><li>&#8595; Hepatic UDP glucuronosyltransferase activity &#8594; &#8595; conjugation of bilirubin</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical findings</strong></p></td><td><ul><li>Recurrent episodes of mild jaundice</li><li>Provoked by stress (eg, febrile illness, fasting, dehydration, vigorous exercise, menstruation, surgery)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><ul><li>&#8593; Unconjugated bilirubin (ie, indirect hyperbilirubinemia)</li><li>Normal CBC, blood smear, reticulocyte count</li><li>Normal AST, ALT, alkaline phosphatase</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Benign; no treatment required</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>ALT</strong> = alanine aminotransferase; <strong>AST</strong> = aspartate aminotransferase; <strong>CBC</strong> = complete blood count.</p></td></tr></tbody></table></div><p>This patient has scleral icterus and indirect (unconjugated) hyperbilirubinemia in the setting of an upper respiratory tract infection (eg, fever, fatigue, nasal discharge, sore throat).&nbsp; This presentation is consistent with <strong>Gilbert syndrome</strong>, the most common inherited disorder of bilirubin glucuronidation.</p><p>Gilbert syndrome is characterized by <strong>episodic jaundice</strong> due to decreased activity of UDP glucuronosyltransferase, the hepatic enzyme responsible for <a href=\"6598\">bilirubin conjugation</a>.&nbsp; These benign episodes can be precipitated by periods of <strong>stress</strong>, such as <strong>febrile illness</strong> (as seen in this patient), dehydration, fasting, vigorous exercise, menstruation, or surgery.</p><p>A presumptive diagnosis of Gilbert syndrome is made based on the presence of persistent <strong>indirect hyperbilirubinemia</strong> in the <strong>absence of other laboratory abnormalities</strong> (eg, hepatic aminotransferases, complete blood count, reticulocyte count).&nbsp; This condition is benign, and reassurance should be provided.</p><p><strong>(Choice A)</strong>&nbsp; Excessive alcohol consumption (typically &gt;6 drinks/day) can lead to alcoholic hepatitis, which causes fever and jaundice.&nbsp; However, aspartate aminotransferase (AST) and alanine aminotransferase (ALT) would be elevated in a &#8805;2:1 ratio.&nbsp; In addition, tender hepatomegaly is typical and in contrast to this patient&#39;s nontender, normal-sized (&#8804;15 cm) liver.</p><p><strong>(Choice B)</strong>&nbsp; Rotor syndrome, a rare autosomal recessive disorder, can cause episodic jaundice due to impaired intrahepatic storage of conjugated bilirubin.&nbsp; However, a predominantly direct (conjugated) hyperbilirubinemia would be expected.</p><p><strong>(Choice D)</strong>&nbsp; Hemolytic anemia, which may be triggered by certain viral infections (eg, Epstein-Barr virus, HIV), increases unconjugated bilirubin production due to red blood cell destruction.&nbsp; In contrast to this patient, a low hemoglobin level and an increased reticulocyte count would be expected in a patient with hemolytic anemia.</p><p><strong>(Choice E)</strong>&nbsp; Acute viral hepatitis can cause fever, jaundice, and hyperbilirubinemia.&nbsp; However, significant elevations in AST and ALT, sometimes exceeding 1,000 U/L, would be expected, making this diagnosis very unlikely.&nbsp; In addition, predominant indirect hyperbilirubinemia in the absence of hemolysis is not common with viral infections.</p><p><strong>Educational objective:</strong><br>Gilbert syndrome is characterized by intermittent jaundice and indirect (unconjugated) hyperbilirubinemia in the absence of other laboratory abnormalities.&nbsp; Jaundice is often triggered by periods of stress, such as febrile illness, dehydration, fasting, vigorous exercise, menses, and surgery.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 1430,
            "topic": "Hereditary hyperbilirubinemias",
            "titleId": 1430,
            "title": "Hereditary hyperbilirubinemias",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Alcohol-mediated hepatocellular injury",
                    "choiceNumber": 1,
                    "correctTaken": 213,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Decreased intracellular storage of bilirubin",
                    "choiceNumber": 2,
                    "correctTaken": 721,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Genetically mediated decreased enzyme activity",
                    "choiceNumber": 3,
                    "correctTaken": 11182,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Infection-induced hemolytic anemia",
                    "choiceNumber": 4,
                    "correctTaken": 3331,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Virus-mediated hepatocellular injury",
                    "choiceNumber": 5,
                    "correctTaken": 2039,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1625,1681,true,-1,1*1949,1978,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22160004",
                    "mediaDataId": 0,
                    "title": "Gilbert syndrome.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22160004",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 96,
            "othersAvgTimeSpent": 76,
            "notes": null,
            "peopleTaken": 17486,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 64,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1149,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 25,
            "questionId": 2912,
            "questionIndex": 2912,
            "questionText": "<p>A 42-year-old woman comes to the office with worsening fatigue and dark yellow urine. &nbsp;She also has anorexia, nausea, mild abdominal pain, and malaise. &nbsp;The patient is uncertain as to when her symptoms began but felt normal during her vacation 4 weeks ago. &nbsp;She has no known medical problems and does not take any medications. &nbsp;The patient does not use alcohol, tobacco, or illicit drugs.&nbsp; She has had unprotected sexual intercourse with 6 different partners within the past year. &nbsp;The patient does not remember getting a hepatitis B vaccination. &nbsp;Laboratory results are as follows:</p><blockquote><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"300\"><tbody><tr><td>Total bilirubin</td><td>5.3 mg/dL</td></tr><tr><td>Alkaline phosphatase</td><td>170 U/L</td></tr><tr><td>Aspartate aminotransferase</td><td>992 U/L</td></tr><tr><td>Alanine aminotransferase</td><td>1290 U/L</td></tr></tbody></table></blockquote><p>Which of the following is the most appropriate test to diagnose hepatitis B infection in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img id=\"2264\"  src=\"https://www.uworld.com/media/L15838.png\" draggable=\"false\" ></p><p>This patient&#39;s new-onset symptoms (eg, fatigue, nausea/abdominal pain, dark urine) and abnormal liver function tests (eg, elevated serum transaminases, hyperbilirubinemia) in the setting of unprotected sex with multiple partners is concerning for <strong>acute hepatitis B infection</strong>.&nbsp; The first serologic marker to appear in the serum with acute hepatitis B is HBsAg, which appears usually 4-8 weeks after infection.&nbsp; IgM anti-HBc appears shortly thereafter, which is around the time clinical symptoms occur and patients develop elevations in hepatic aminotransferase levels (often &gt;25 times the normal limit).</p><p>There can be a time lag (weeks to months) between the disappearance of HBsAg and the appearance of anti-HBs, which is termed the <strong>window period</strong>.&nbsp; IgM anti-HBc may be the only detectable marker for acute hepatitis B infection during this period.&nbsp; As such, <strong>HBsAg</strong> and <strong>anti-HBc</strong> are the most appropriate diagnostic tests for acute hepatitis B infection as these are both elevated during initial infection and anti-HBc will remain elevated during the window period.</p><p><strong>(Choice A)</strong>&nbsp; HBcAg is not detectable in serum and is therefore not useful for establishing the diagnosis.</p><p><strong>(Choice B)</strong>&nbsp; HBeAg is a good indicator of infectivity but is a poor test for acute hepatitis B infection as levels typically fall early in the course of the disease.</p><p><strong>(Choice C)</strong>&nbsp; Testing for HBsAg and anti-HBs can miss the diagnosis of acute hepatitis B infection in patients who are in the window period.</p><p><strong>(Choice E)</strong>&nbsp; Although hepatitis B virus DNA may be detectable prior to the appearance of HBsAg or HBeAg, this test is generally not performed to diagnose acute infection.&nbsp; Instead, hepatitis B virus DNA is obtained in patients with chronic hepatitis B to determine candidacy for antiviral therapy or monitor response to treatment.</p><p><strong>Educational objective:</strong><br>HBsAg and anti-HBc are the most appropriate diagnostic tests for acute hepatitis B infection as they are both elevated during initial infection and anti-HBc will remain elevated during the window period.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 7134,
            "topic": "Hepatitis b",
            "titleId": 7134,
            "title": "Hepatitis b",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "4",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "HBcAg",
                    "choiceNumber": 1,
                    "correctTaken": 6407,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "HBeAg",
                    "choiceNumber": 2,
                    "correctTaken": 7728,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "HBsAg and anti-HBs",
                    "choiceNumber": 3,
                    "correctTaken": 15142,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "HBsAg and IgM anti-HBc",
                    "choiceNumber": 4,
                    "correctTaken": 68901,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hepatitis B virus DNA",
                    "choiceNumber": 5,
                    "correctTaken": 8639,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "308,441,true,-1,1*1682,1832,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20387772",
                    "mediaDataId": 0,
                    "title": "Hepatitis B: diagnosis and treatment.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20387772",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24954675",
                    "mediaDataId": 0,
                    "title": "Hepatitis B virus infection.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24954675",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 72,
            "othersAvgTimeSpent": 63,
            "notes": null,
            "peopleTaken": 106817,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 65,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 653,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 26,
            "questionId": 2908,
            "questionIndex": 2908,
            "questionText": "<p>A 58-year-old man comes to the office due to increasing abdominal girth for the past several months.&nbsp; The patient also reports progressive fatigue, weight gain, and nausea but no vomiting.&nbsp; Medical history is significant for gastroesophageal reflux and hypertension.&nbsp; He drinks 12 beers a day but denies smoking or intravenous drug use.&nbsp; Temperature is 37 C (98.6 F), blood pressure is 122/76 mm Hg, pulse is 80/min, and respirations are 18/min.&nbsp; Mental status is normal.&nbsp; Cardiopulmonary examination is unremarkable.&nbsp; The abdomen is grossly distended, and shifting dullness is elicited.&nbsp; There is no asterixis.&nbsp; Chest x-ray is normal.&nbsp; Basic metabolic panel is unremarkable.&nbsp; Abdominal ultrasonogram shows splenomegaly, moderate ascites, and a shrunken liver with no masses.&nbsp; Diagnostic paracentesis reveals straw-colored fluid.&nbsp; In addition to recommending complete abstinence from alcohol use, which of the following is the best next step in management?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T54987\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Management of ascites in cirrhosis</strong></p></td></tr><tr><td><p align=\"center\"><strong>Initial evaluation</strong></p></td><td><ul><li>Imaging for confirmation (eg, abdominal ultrasound)</li><li>Diagnostic paracentesis to confirm etiology &amp; rule out infection<ul style=\"list-style-type:circle;\"><li>SAAG, cell count &amp; differential, total protein</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Medical therapy</strong></p></td><td><ul><li>Spironolactone with furosemide</li><li>Alcohol abstinence, sodium restriction</li><li>Avoid ACE inhibitors, angiotensin receptor blockers, NSAIDs</li></ul></td></tr><tr><td><p align=\"center\"><strong>Refractory ascites</strong></p></td><td><ul><li>Large-volume paracentesis</li><li>Transjugular intrahepatic portosystemic shunt</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>NSAIDs</strong> = nonsteroidal anti-inflammatory drugs; <strong>SAAG</strong> = serum-ascites albumin gradient.</p></td></tr></tbody></table></div><p>This patient with a history of heavy alcohol use has new-onset <strong>ascites</strong> and a shrunken liver on ultrasound, suggesting <strong>decompensated cirrhosis</strong>.&nbsp; Portal hypertension in cirrhosis leads to hemodynamic changes (eg, splanchnic vasodilation) that promotes fluid and sodium retention, ultimately resulting in ascites and peripheral edema.</p><p>The workup of ascites is directed at confirming the underlying etiology and ruling out infection.&nbsp; In addition to imaging (eg, abdominal ultrasound), a <strong>diagnostic paracentesis</strong> should be performed in all patients.&nbsp; Ascites from cirrhosis is usually yellowish or <strong>straw-colored</strong>; analysis reveals low total protein (&lt;2.5 g/dL) and a high serum-ascites albumin gradient (&#8805;1.1).&nbsp; Cell count and differential should be obtained to rule out spontaneous bacterial peritonitis (ie, neutrophil count &#8805;250/mm<font size=\"2\"><sup>3</sup></font>).</p><p>Management includes <strong>sodium restriction</strong> as well as <strong>spironolactone</strong> and <strong>furosemide</strong>, which improve both ascitic fluid retention and peripheral edema.&nbsp; These medications are usually used concurrently to increase the efficacy of natriuresis and prevent electrolyte disturbances.&nbsp; <strong>Alcohol abstinence</strong> is also important since cessation improves portal hypertension and decreases ascites.&nbsp; Large-volume paracentesis or transjugular intrahepatic portosystemic shunt may be required for refractory ascites.</p><p><strong>(Choice A)</strong>&nbsp; Fluid restriction is used to treat hypervolemic hyponatremia.&nbsp; Although hyponatremia can develop in cirrhosis, fluid restriction is not indicated in patients with normal sodium levels, such as this patient.</p><p><strong>(Choice B)</strong>&nbsp; Although spironolactone is occasionally used by itself in patients prone to hypokalemia, furosemide monotherapy is usually avoided in cirrhosis because it is less effective in this population and predisposes to electrolyte wasting.</p><p><strong>(Choice D)</strong>&nbsp; Patients with cirrhosis have low mean arterial pressure due to splanchnic vasodilation and are dependent on the renin-angiotensin-aldosterone system to help normalize blood pressure and renal perfusion.&nbsp; ACE inhibitors (eg, lisinopril) and angiotensin receptor blockers blunt this critical response and promote organ hypoperfusion in this group.&nbsp; These medications should be avoided in patients with cirrhosis.</p><p><strong>(Choice E)</strong>&nbsp; Periodic large-volume paracentesis is used in those whose condition fails to improve with diuretics or who develop diuretic-related side effects (eg, acute kidney injury, electrolyte disturbances).&nbsp; It is invasive and not recommended prior to a trial of spironolactone and furosemide.</p><p><strong>Educational objective:</strong><br>Workup of ascites includes ultrasonography and a diagnostic paracentesis (ie, serum-ascites albumin gradient, cell count and differential, total protein) to determine the underlying etiology and rule out spontaneous bacterial peritonitis.&nbsp; Initial management of ascites from cirrhosis includes spironolactone and furosemide, sodium restriction, and alcohol abstinence.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 205,
            "system": "Gastrointestinal & Nutrition",
            "topicId": 2874,
            "topic": "Cirrhosis",
            "titleId": 2874,
            "title": "Cirrhosis",
            "topicAttributeId": 330608,
            "topicAttribute": "Hepatic disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Fluid restriction",
                    "choiceNumber": 1,
                    "correctTaken": 1122,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Furosemide alone",
                    "choiceNumber": 2,
                    "correctTaken": 3877,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Furosemide and spironolactone",
                    "choiceNumber": 3,
                    "correctTaken": 10782,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lisinopril",
                    "choiceNumber": 4,
                    "correctTaken": 239,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Weekly large-volume paracentesis",
                    "choiceNumber": 5,
                    "correctTaken": 1100,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "19570764",
                    "mediaDataId": 0,
                    "title": "Combined versus sequential diuretic treatment of ascites in non-azotaemic patients with cirrhosis: results of an open randomised clinical trial.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/19570764",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 57,
            "othersAvgTimeSpent": 60,
            "notes": null,
            "peopleTaken": 17120,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 63,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 441,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        }
    ],
    "abstractList": null,
    "deckList": [
        {
            "deckId": 9788456,
            "deckName": "Notes",
            "deckColor": "#36c8a3",
            "isDefault": true,
            "dateCreated": "01/01/0001 12:00:00 AM",
            "noOfFlashCards": 4,
            "groupId": null,
            "studySettingsId": null,
            "lastStudyDate": null,
            "isCustomStudyDeck": false,
            "parentDeckId": null,
            "customStudySettings": null,
            "subscriptionId": 0
        }
    ],
    "newExamYearQuestionList": null,
    "flashCardList": null,
    "questionModes": [
        {
            "id": 4,
            "name": "CUSTOM"
        }
    ],
    "subscriptionElapsedTime": 0.0,
    "isFacultyControlled": null,
    "endCATTest": null,
    "questionSourceIds": null
}